Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Ischemic Heart Disease

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 697 articles:
HTML format



Single Articles


    May 2020
  1. JENSEN LO, Maeng M, Raungaard B, Kahlert J, et al
    Randomised Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated with Percutaneous Coronary Intervention: The SORT OUT IX Trial
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.119.040241.
    PubMed     Abstract available


  2. PANDEY A, Keshvani N, Vaughan-Sarrazin MS, Gao Y, et al
    Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries.
    Circulation. 2020 May 15. doi: 10.1161/CIRCULATIONAHA.119.044765.
    PubMed     Abstract available


  3. NAGELE P
    A Simplified Proposal to Redefine Acute Myocardial Infarction Versus Acute Myocardial Injury.
    Circulation. 2020;141:1431-1433.
    PubMed    


  4. SANDOVAL Y, Thygesen K, Jaffe AS
    The Universal Definition of Myocardial Infarction: Present and Future.
    Circulation. 2020;141:1434-1436.
    PubMed    


  5. KOHLI P, Virani SS
    Surfing the Waves of the COVID-19 Pandemic As A Cardiovascular Clinician.
    Circulation. 2020 May 5. doi: 10.1161/CIRCULATIONAHA.120.047901.
    PubMed    


  6. MEHTA LS, Warnes CA, Bradley E, Burton T, et al
    Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association.
    Circulation. 2020 May 4:CIR0000000000000772. doi: 10.1161/CIR.0000000000000772.
    PubMed     Abstract available


    April 2020
  7. STEFANINI GG, Montorfano M, Trabattoni D, Andreini D, et al
    ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes.
    Circulation. 2020 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.047525.
    PubMed    


  8. PICCOLO R, Bruzzese D, Mauro C, Aloia A, et al
    Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated with the COVID-19 Outbreak.
    Circulation. 2020 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.047457.
    PubMed    


  9. ARMSTRONG PW
    Enhancing Cardiovascular Care: Global Collaboration Is How It Happens.
    Circulation. 2020;141:1357-1359.
    PubMed    


  10. SAAD M, Meyer-Saraei R, de Waha-Thiele S, Stiermaier T, et al
    Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Ticagrelor-Induced Platelet Inhibition in Acute Myocardial Infarction: The Randomized MonAMI Trial.
    Circulation. 2020;141:1354-1356.
    PubMed    


  11. ZHOU H, Zhao YT
    Anterior ST-Segment Elevation Myocardial Infarction Without ST Elevation in Lead V1: Where Is the Culprit Lesion?
    Circulation. 2020;141:1351-1353.
    PubMed    



  12. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2020;141:e773.
    PubMed    


  13. ARAI AE, Hsu LY
    Global Developments in Stress Perfusion Cardiovascular Magnetic Resonance.
    Circulation. 2020;141:1292-1294.
    PubMed    


  14. AENGEVAEREN VL, Mosterd A, Sharma S, Prakken NHJ, et al
    Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management.
    Circulation. 2020;141:1338-1350.
    PubMed     Abstract available



  15. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2020;141:e774.
    PubMed    


  16. VETROVEC G, Stravitz RT
    Bleeding in Patients With Cirrhosis Undergoing Invasive Cardiovascular Procedures: Do We Overestimate Risk?
    Circulation. 2020;141:1279-1281.
    PubMed    


  17. SPERLING LS
    The Future of Cardiovascular Prevention: Unprecedented Times.
    Circulation. 2020 Apr 20. doi: 10.1161/CIRCULATIONAHA.120.047059.
    PubMed    


  18. DUFFY EY, Cainzos-Achirica M, Michos ED
    Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic.
    Circulation. 2020 Apr 20. doi: 10.1161/CIRCULATIONAHA.120.047194.
    PubMed    


  19. ZHOU X, Li Y, Yang Q
    Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications from Clinical Features to Pathological Findings.
    Circulation. 2020 Apr 16. doi: 10.1161/CIRCULATIONAHA.120.046988.
    PubMed    


  20. HENDREN NS, Drazner MH, Bozkurt B, Cooper LT Jr, et al
    Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
    Circulation. 2020 Apr 16. doi: 10.1161/CIRCULATIONAHA.120.047349.
    PubMed     Abstract available


  21. LIU PP, Blet A, Smyth D, Li H, et al
    The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Circulation. 2020 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.047549.
    PubMed     Abstract available


  22. ORTEGA-PAZ L, Brugaletta S, Gomez-Lara J, Sabate M, et al
    Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".
    Circulation. 2020;141:e748-e749.
    PubMed    


  23. CONSUEGRA-SANCHEZ L, Ong P, Kaski JC
    Letter by Consuegra-Sanchez et al Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".
    Circulation. 2020;141:e746-e747.
    PubMed    


  24. CLIMIE RE, Marques FZ
    Impact, Strategies and Opportunities for Early and Mid-Career Cardiovascular Researchers During the COVID-19 Pandemic.
    Circulation. 2020 Apr 14. doi: 10.1161/CIRCULATIONAHA.120.047394.
    PubMed    


  25. KOJIMA Y, Ye J, Nanda V, Wang Y, et al
    Knockout of the Murine Ortholog to the Human 9p21 Coronary Artery Disease Locus Leads to Smooth Muscle Cell Proliferation, Vascular Calcification, and Advanced Atherosclerosis.
    Circulation. 2020;141:1274-1276.
    PubMed    


  26. ARNOLD SV, Bhatt DL, Barsness GW, Beatty AL, et al
    Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Apr 13:CIR0000000000000766. doi: 10.1161/CIR.0000000000000766.
    PubMed     Abstract available


  27. EDELSON DP, Sasson C, Chan PS, Atkins DL, et al
    Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the Guidelines((R))-Resuscitation Adult and Pediatric Task Force
    Circulation. 2020 Apr 9. doi: 10.1161/CIRCULATIONAHA.120.047463.
    PubMed     Abstract available


  28. PARK JH, Kim DH, Park YG, Kwon DY, et al
    Association of Parkinson Disease With Risk of Cardiovascular Disease and All-Cause Mortality: A Nationwide, Population-Based Cohort Study.
    Circulation. 2020;141:1205-1207.
    PubMed    


  29. PARK DW, Park SJ
    Response by Park and Park to Letter Regarding Article, "Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial".
    Circulation. 2020;141:e741-e742.
    PubMed    


  30. CHEN ZQ, Chen F, Li L
    Letter by Chen et al Regarding Article, "Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial".
    Circulation. 2020;141:e739-e740.
    PubMed    


  31. ROSENGREN A, Wallentin L
    Cardiovascular Medicine in Sweden: Improvement by Continuous Measuring.
    Circulation. 2020;141:1124-1126.
    PubMed    


  32. KIM Y, Johnson TW, Jeong MH
    Letter by Kim et al Regarding Article, "Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial".
    Circulation. 2020;141:e737-e738.
    PubMed    


  33. VIRANI SS, Smith SC Jr, Stone NJ, Grundy SM, et al
    Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia.
    Circulation. 2020;141:1121-1123.
    PubMed    


  34. FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
    The Variety of Cardiovascular Presentations of COVID-19.
    Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
    PubMed    


  35. CAINZOS-ACHIRICA M, Miedema MD, McEvoy JW, Al Rifai M, et al
    Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2020 Apr 1. doi: 10.1161/CIRCULATIONAHA.119.045010.
    PubMed     Abstract available


    March 2020
  36. DEMPSEY PC, Strain T, Khaw KT, Wareham NJ, et al
    Prospective Associations of Accelerometer-Measured Physical Activity and Sedentary Time With Incident Cardiovascular Disease, Cancer, and All-Cause Mortality.
    Circulation. 2020;141:1113-1115.
    PubMed    


  37. PARK DW, Ahn JM, Park H, Yun SC, et al
    Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046039.
    PubMed    


  38. ALFONSO F, Kastrati A
    Ten-Year Follow-Up of Left Main Coronary Artery Revascularization: Still Equipoise Between Percutaneous Interventions and Surgery?
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046154.
    PubMed    


  39. ALAHMAD B, Khraishah H, Shakarchi AF, Albaghdadi M, et al
    Cardiovascular Mortality and Exposure to Heat in an Inherently Hot Region: Implications for Climate Change.
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.119.044860.
    PubMed    


  40. SCHWARTZ GG, Steg PG, Szarek M, Bittner VA, et al
    Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of a Randomized Clinical Trial.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046524.
    PubMed     Abstract available


  41. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    PubMed     Abstract available


  42. BHATT DL, Eikelboom JW, Connolly SJ, Steg PG, et al
    The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial.
    Circulation. 2020 Mar 28. doi: 10.1161/CIRCULATIONAHA.120.046448.
    PubMed     Abstract available


  43. HAN Y, Zeng H, Jiang H, Yang Y, et al
    CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic.
    Circulation. 2020 Mar 27. doi: 10.1161/CIRCULATIONAHA.120.047011.
    PubMed    


  44. MA L, Liu G, Ding M, Zong G, et al
    Isoflavone Intake and the Risk of Coronary Heart Disease in US Men and Women: Results From 3 Prospective Cohort Studies.
    Circulation. 2020 Mar 23. doi: 10.1161/CIRCULATIONAHA.119.041306.
    PubMed    


  45. CLERKIN KJ, Fried JA, Raikhelkar J, Sayer G, et al
    Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease.
    Circulation. 2020 Mar 21. doi: 10.1161/CIRCULATIONAHA.120.046941.
    PubMed    


  46. BAINEY KR, Welsh RC, Connolly SJ, Marsden T, et al
    Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients with Prior Percutaneous Coronary Intervention (COMPASS-PCI).
    Circulation. 2020 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.044598.
    PubMed     Abstract available


  47. WILLIAMS MC, Kwiecinski J, Doris M, McElhinney P, et al
    Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART).
    Circulation. 2020 Mar 16. doi: 10.1161/CIRCULATIONAHA.119.044720.
    PubMed    


  48. REDDY KS, Prabhakaran D
    Reducing the Risk of Cardiovascular Disease: Brick by BRICS.
    Circulation. 2020;141:800-802.
    PubMed    


  49. TSUDA K
    Letter by Tsuda Regarding Article, "Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial".
    Circulation. 2020;141:e100-e101.
    PubMed    


    February 2020
  50. KUHN TC, Knobel J, Burkert-Rettenmaier S, Li X, et al
    Secretome Analysis of Cardiomyocytes Identifies PCSK6 as a Novel Player in Cardiac Remodeling After Myocardial Infarction.
    Circulation. 2020 Feb 26. doi: 10.1161/CIRCULATIONAHA.119.044914.
    PubMed     Abstract available


  51. FRANKLIN BA, Thompson PD, Al-Zaiti SS, Albert CM, et al
    Exercise-Related Acute Cardiovascular Events and Potential Deleterious Adaptations Following Long-Term Exercise Training: Placing the Risks Into Perspective-An Update: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Feb 26:CIR0000000000000749. doi: 10.1161/CIR.0000000000000749.
    PubMed     Abstract available


  52. KAYE DM, Shihata W, Jama HA, Tsyganov K, et al
    Deficiency of Prebiotic Fibre and Insufficient Signalling Through Gut Metabolite Sensing Receptors Leads to Cardiovascular Disease.
    Circulation. 2020 Feb 25. doi: 10.1161/CIRCULATIONAHA.119.043081.
    PubMed     Abstract available


  53. LEVIN MG, Rader DJ
    Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?
    Circulation. 2020;141:637-640.
    PubMed    


  54. MEFFORD MT, Li BH, Qian L, Reading SR, et al
    Sex-Specific Trends in Acute Myocardial Infarction Within an Integrated Healthcare Network, 2000 Through 2014.
    Circulation. 2020;141:509-519.
    PubMed     Abstract available


  55. XIA S, Du X, Guo L, Du J, et al
    Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China.
    Circulation. 2020;141:530-539.
    PubMed     Abstract available


  56. CASADEI B, Rutherford JD
    Building a Career in Cardiovascular Research: A Conversation With Barbara Casadei, MD, DPhil.
    Circulation. 2020;141:504-508.
    PubMed    


  57. AGARWALA A, Michos ED, Samad Z, Ballantyne CM, et al
    The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.
    Circulation. 2020;141:592-599.
    PubMed     Abstract available


  58. KHOSROW-KHAVAR F, Filion KB, Bouganim N, Suissa S, et al
    Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.
    Circulation. 2020;141:549-559.
    PubMed     Abstract available


  59. JIN X, Chandramouli C, Allocco B, Gong E, et al
    Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017.
    Circulation. 2020;141:540-548.
    PubMed     Abstract available


  60. KUWABARA M, Sasaki J, Saikawa T, Ouchi Y, et al
    Response by Kuwabara et al to Letter Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial".
    Circulation. 2020;141:e67-e68.
    PubMed    


  61. WEINGARTNER O, Sijbrands E, Lutjohann D
    Letter by Weingartner et al Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial".
    Circulation. 2020;141:e65-e66.
    PubMed    


    January 2020
  62. HADAS Y, Vincek AS, Youssef E, Zak MM, et al
    Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response after Myocardial Infarction.
    Circulation. 2020 Jan 29. doi: 10.1161/CIRCULATIONAHA.119.041882.
    PubMed     Abstract available


  63. SHARMA A, Pagidipati NJ, Califf RM, McGuire DK, et al
    Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
    Circulation. 2020 Jan 29. doi: 10.1161/CIRCULATIONAHA.119.041022.
    PubMed     Abstract available


  64. ROGER VL, Sidney S, Fairchild AL, Howard VJ, et al
    Recommendations for Cardiovascular Health and Disease Surveillance for 2030 and Beyond: A Policy Statement From the American Heart Association.
    Circulation. 2020 Jan 29:CIR0000000000000756. doi: 10.1161/CIR.0000000000000756.
    PubMed     Abstract available



  65. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2020;141:e60.
    PubMed    



  66. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2020;141:e59.
    PubMed    


  67. MORROW DA
    The Fourth Universal Definition of Myocardial Infarction and the Emerging Importance of Myocardial Injury.
    Circulation. 2020;141:172-175.
    PubMed    


  68. KALRA A, Kumbhani DJ, Hill JA
    Cardiovascular Science India Tour: Impacting Cardiovascular Disease in South Asia.
    Circulation. 2020;141:159-160.
    PubMed    


  69. SREEJIT G, Abdel-Latif A, Athmanathan B, Annabathula R, et al
    Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis Following Myocardial Infarction.
    Circulation. 2020 Jan 16. doi: 10.1161/CIRCULATIONAHA.119.043833.
    PubMed     Abstract available


  70. SORIA-FLORIDO MT, Castaner O, Lassale C, Estruch R, et al
    Dysfunctional HDLs are Associated with a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested-Case Control Study.
    Circulation. 2020 Jan 16. doi: 10.1161/CIRCULATIONAHA.119.041658.
    PubMed     Abstract available


  71. ZOU Z, Cini K, Dong B, Ma Y, et al
    Time Trends in Cardiovascular Disease Mortality Across the BRICS: An Age-Period-Cohort Analysis of Key Nations with Emerging Economies Using the Global Burden of Disease Study 2017.
    Circulation. 2020 Jan 16. doi: 10.1161/CIRCULATIONAHA.119.042864.
    PubMed     Abstract available


  72. KUEHN BM
    Childhood Risk Factors Contribute to Cardiovascular Events in Adults.
    Circulation. 2020;141:147-148.
    PubMed    


  73. NEELAKANTAN N, Seah JYH, van Dam RM
    The Effect of Coconut Oil Consumption on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Clinical Trials.
    Circulation. 2020 Jan 13. doi: 10.1161/CIRCULATIONAHA.119.043052.
    PubMed     Abstract available


  74. KAYIKCIOGLU M, Oto A
    Control and Management of Cardiovascular Disease in Turkey.
    Circulation. 2020;141:7-9.
    PubMed    


  75. RAPHAEL CE, Roger VL, Sandoval Y, Singh M, et al
    Incidence, Trends and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Circulation. 2020 Jan 6. doi: 10.1161/CIRCULATIONAHA.119.043100.
    PubMed     Abstract available


    December 2019
  76. BUTLER J, Packer M, Greene SJ, Fiuzat M, et al
    Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
    Circulation. 2019;140:2108-2118.
    PubMed     Abstract available


  77. CARSON JAS, Lichtenstein AH, Anderson CAM, Appel LJ, et al
    Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association.
    Circulation. 2019 Dec 16:CIR0000000000000743. doi: 10.1161/CIR.0000000000000743.
    PubMed     Abstract available


  78. GRANDI SM, Smith GN, Platt RW
    The Relative Contribution of Pregnancy Complications to Cardiovascular Risk Prediction: Are We Getting It Wrong?
    Circulation. 2019;140:1965-1967.
    PubMed    


  79. WELSH P, Welsh C, Pell J, Sattar N, et al
    Response by Welsh et al to Letter Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease".
    Circulation. 2019;140:e824-e825.
    PubMed    


  80. SNIDERMAN AD, Thanassoulis G, Pencina M
    Letter by Sniderman et al Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease".
    Circulation. 2019;140:e822-e823.
    PubMed    


  81. SKRANES JB, Claggett BL, Myhre PL, Lyngbakken MN, et al
    Current Smoking Is Associated With Lower Concentrations of High-Sensitivity Cardiac Troponin T in Patients With Stable Coronary Artery Disease: The PEACE Trial.
    Circulation. 2019;140:2044-2046.
    PubMed    


  82. GIUSTINO G, Leon MB, Stone GW
    Highlights of Transcatheter Cardiovascular Therapeutics 2019.
    Circulation. 2019;140:1943-1945.
    PubMed    


    November 2019
  83. BAJAJ NS, Singh A, Zhou W, Gupta A, et al
    Coronary Microvascular Dysfunction, Left Ventricular Remodeling and Clinical Outcomes in Patients with Chronic Kidney Impairment.
    Circulation. 2019 Nov 29. doi: 10.1161/CIRCULATIONAHA.119.043916.
    PubMed     Abstract available


  84. DE LEMOS JA, Newby LK, Mills NL
    A Proposal for Modest Revision of the Definition of Type 1 and Type 2 Myocardial Infarction.
    Circulation. 2019;140:1773-1775.
    PubMed    


  85. KHERA R, Valero-Elizondo J, Das SR, Virani SS, et al
    Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017.
    Circulation. 2019 Nov 25. doi: 10.1161/CIRCULATIONAHA.119.041974.
    PubMed    


  86. HUANG LUCAS C, Wu L, Yue B, Bachoo N, et al
    Abstract 10613: Symptomatic Human Immunodeficiency Virus Infected Patients Receive Less Aggressive Revascularization Management After Acute Coronary Syndrome, a 5-year Nationwide Analysis.
    Circulation. 2019;140.
    PubMed     Abstract available


  87. ORTEGA RF, Yancy CW, Mehran R, Batchelor W, et al
    Overcoming Lack of Diversity in Cardiovascular Clinical Trials: A New Challenge and Strategies for Success.
    Circulation. 2019;140:1690-1692.
    PubMed    


  88. TAEGTMEYER H, Dasgupta P
    Chronos and Kairos in Lockstep: Thoughts on the Enduring Productivity of Cardiovascular Investigators.
    Circulation. 2019;140:1687-1689.
    PubMed    


  89. PETRIE MC
    Sodium Glucose Cotransporter 2 Inhibitors: Searching for Mechanisms in the Wake of Large, Positive Cardiovascular Outcomes Trials.
    Circulation. 2019;140:1703-1705.
    PubMed    


  90. AMIN AP, Spertus JA, Curtis JP, Desai N, et al
    The Evolving Landscape of Impella(R) Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention with Mechanical Circulatory Support.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044007.
    PubMed     Abstract available


  91. ESCOBEDO MB, Aziz K, Kapadia VS, Lee HC, et al
    2019 American Heart Association Focused Update on Neonatal Resuscitation: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2019 Nov 14:CIR0000000000000729. doi: 10.1161/CIR.0000000000000729.
    PubMed     Abstract available


  92. PANCHAL AR, Berg KM, Cabanas JG, Kurz MC, et al
    2019 American Heart Association Focused Update on Systems of Care: Dispatcher-Assisted Cardiopulmonary Resuscitation and Cardiac Arrest Centers: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Car
    Circulation. 2019 Nov 14:CIR0000000000000733. doi: 10.1161/CIR.0000000000000733.
    PubMed     Abstract available


  93. PANCHAL AR, Berg KM, Hirsch KG, Kudenchuk PJ, et al
    2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support: Use of Advanced Airways, Vasopressors, and Extracorporeal Cardiopulmonary Resuscitation During Cardiac Arrest: An Update to the American Heart Association Guidelin
    Circulation. 2019 Nov 14:CIR0000000000000732. doi: 10.1161/CIR.0000000000000732.
    PubMed     Abstract available


  94. DUFF JP, Topjian AA, Berg MD, Chan M, et al
    2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2019 Nov 14:CIR0000000000000731. doi: 10.1161/CIR.0000000000000731.
    PubMed     Abstract available


  95. DUFF JP, Topjian AA, Berg MD, Chan M, et al
    2019 American Heart Association Focused Update on Pediatric Basic Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2019 Nov 14:CIR0000000000000736. doi: 10.1161/CIR.0000000000000736.
    PubMed     Abstract available


  96. SOAR J, Maconochie I, Wyckoff MH, Olasveengen TM, et al
    2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2019 Nov 14:CIR0000000000000734. doi: 10.1161/CIR.0000000000000734.
    PubMed     Abstract available


  97. RAGGI P, Bellasi A, Bushinsky D, Bover J, et al
    Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044195.
    PubMed     Abstract available


  98. BICK AG, Pirruccello JP, Griffin GK, Gupta N, et al
    Genetic IL-6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044362.
    PubMed     Abstract available


  99. RAHMAN H, Ryan M, Lumley M, Modi B, et al
    Coronary Microvascular Dysfunction Is Associated With Myocardial Ischemia and Abnormal Coronary Perfusion During Exercise.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.041595.
    PubMed    


  100. LOPES RD, Leonardi S, Wojdyla DM, Vora AN, et al
    Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044584.
    PubMed     Abstract available


  101. DAMASK A, Steg PG, Schwartz GG, Szarek M, et al
    Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044434.
    PubMed     Abstract available


  102. SHAW LJ, Reynolds HR, Picard MH
    A Leap Forward for Ischemia-Guided Revascularization: Stress Echocardiography Predicts Angina Benefit With Percutaneous Coronary Intervention.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044026.
    PubMed    


  103. AL-LAMEE RK, Shun-Shin MJ, Howard JP, Nowbar AN, et al
    Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.042918.
    PubMed    


  104. CANNON CP, Perkovic V, Agarwal R, Baldassarre J, et al
    Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044359.
    PubMed     Abstract available


  105. MAZER CD, Hare GMT, Connelly PW, Gilbert RE, et al
    Effect of Empagliflozin on Erythropoietin Levels, Iron Stores and Red Blood Cell Morphology in Patients with Type 2 Diabetes and Coronary Artery Disease.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044235.
    PubMed     Abstract available


  106. FEARON WF, De Bruyne B
    The Shifting Sands of Coronary Microvascular Dysfunction.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043952.
    PubMed    


    October 2019
  107. ROE MT, Strickler J
    Addressing the Conundrum of Bleeding and Cancer Detection With Antithrombotic Therapies for Chronic Atherosclerotic Cardiovascular Disease.
    Circulation. 2019;140:1460-1462.
    PubMed    


  108. MCCAW ZR, Yin G, Wei LJ
    Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies.
    Circulation. 2019;140:1366-1368.
    PubMed    


  109. SATTAR N, Rawshani A, Franzen S
    Response by Sattar et al to Letters Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".
    Circulation. 2019;140:e724-e725.
    PubMed    


  110. WANG J, Xu Y
    Letter by Wang and Xu Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".
    Circulation. 2019;140:e722-e723.
    PubMed    


  111. AGRAWAL A
    Developing "Vital Capacity" in Cardiovascular Risk Assessment.
    Circulation. 2019;140:1291-1292.
    PubMed    


  112. TROMP J, Hage C, Ouwerkerk W, Sanders-van Wijk S, et al
    Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;140:1359-1361.
    PubMed    


  113. WANG D, Chen T, Yang X
    Letter by Wang et al Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".
    Circulation. 2019;140:e720-e721.
    PubMed    



  114. Correction to: Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevencion con Dieta Mediterranea).
    Circulation. 2019;140:e726.
    PubMed    


  115. RUEL M, Gardner TJ
    Introduction to the 2019 Cardiovascular Surgery-Themed Issue.
    Circulation. 2019;140:1231-1232.
    PubMed    


  116. GODOY LC, Rao V, Farkouh ME
    Coronary Revascularization of Patients With Diabetes Mellitus in the Setting of Acute Coronary Syndromes.
    Circulation. 2019;140:1233-1235.
    PubMed    


  117. CHAPMAN AR, Adamson PD, Shah ASV, Anand A, et al
    High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction.
    Circulation. 2019 Oct 7. doi: 10.1161/CIRCULATIONAHA.119.042960.
    PubMed     Abstract available


  118. BURROUGHS PENA MS, Mbassa RS, Slopen NB, Williams DR, et al
    Response by Burroughs Pena et al to Letter Regarding Article, "Cumulative Psychosocial Stress and Ideal Cardiovascular Health in Older Women".
    Circulation. 2019;140:e716-e717.
    PubMed    


  119. DIAZ R, Tajer C
    Current Status and Future Strategies for Cardiovascular Disease in Argentina.
    Circulation. 2019;140:1137-1139.
    PubMed    


  120. VIGNAC M, Pechmajou L, Gaye B
    Letter by Vignac et al Regarding Article, "Cumulative Psychosocial Stress and Ideal Cardiovascular Health in Older Women".
    Circulation. 2019;140:e715.
    PubMed    


  121. TIAN R, Colucci WS, Arany Z, Bachschmid MM, et al
    Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure-A Report from the 2018 National Heart, Lung, and Blood Institute Workshop
    Circulation. 2019;140:1205-1216.
    PubMed     Abstract available


    September 2019
  122. WATANABE H, Domei T, Morimoto T, Natsuaki M, et al
    Very Short Dual Antiplatelet Therapy after Drug-eluting Stent Implantation in Patients with High Bleeding Risk: Insight from the STOPDAPT-2 Trial.
    Circulation. 2019 Sep 27. doi: 10.1161/CIRCULATIONAHA.119.043613.
    PubMed     Abstract available


  123. WINDECKER S, Lopes RD, Massaro T, Jones-Burton C, et al
    Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 26. doi: 10.1161/CIRCULATIONAHA.119.043308.
    PubMed     Abstract available


  124. SABATE M, Alfonso F, Cequier A, Romani S, et al
    Magnesium-Based Resorbable Scaffold versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043467.
    PubMed     Abstract available


  125. PARK DW, Kwon O, Jang JS, Yun SC, et al
    Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.041766.
    PubMed    


  126. VORA AN, Alexander JH, Wojdyla D, Aronson R, et al
    Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043754.
    PubMed     Abstract available


  127. MARQUIS-GRAVEL G, Roe MT, Harrington RA, Munoz D, et al
    Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019;140:1115-1124.
    PubMed     Abstract available


  128. LEON LJ, McCarthy FP, Direk K, Gonzalez-Izquierdo A, et al
    Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A CALIBER Study.
    Circulation. 2019;140:1050-1060.
    PubMed     Abstract available


  129. MARSTON NA, Giugliano RP, Im K, Silverman MG, et al
    Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
    Circulation. 2019 Sep 18. doi: 10.1161/CIRCULATIONAHA.119.041998.
    PubMed     Abstract available


  130. SCHRAGE B, Schneider S, Zeymer U, Thiele H, et al
    Response by Schrage et al to Letter Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".
    Circulation. 2019;140:e559-e560.
    PubMed    


  131. O'NEILL WW, Ohman EM
    Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".
    Circulation. 2019;140:e557-e558.
    PubMed    


  132. DELMAS C, Laine M, Bonello L
    Letter by Delmas et al Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".
    Circulation. 2019;140:e555-e556.
    PubMed    


  133. TERPENING CM
    A Call for More Complete Reporting of Cardiovascular Death.
    Circulation. 2019;140:887-888.
    PubMed    



  134. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2019;140:e647-e648.
    PubMed    



  135. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2019;140:e649-e650.
    PubMed    


  136. CHEW DP, Lambrakis K, Blyth A, Seshadri A, et al
    A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible ACS In the Emergency Department with High Sensitivity Troponin T (RAPID-TnT) Study.
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.042891.
    PubMed     Abstract available


  137. ROE MT, Li QH, Bhatt DL, Bittner VA, et al
    Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
    Circulation. 2019 Sep 2. doi: 10.1161/CIRCULATIONAHA.119.042551.
    PubMed    


  138. BULARGA A, Lee KK, Stewart S, Ferry AV, et al
    High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary Syndrome.
    Circulation. 2019 Sep 1. doi: 10.1161/CIRCULATIONAHA.119.042866.
    PubMed     Abstract available


    August 2019
  139. COLANTONIO LD, Muntner P
    It Is Time for Reducing Global Cardiovascular Mortality.
    Circulation. 2019;140:726-728.
    PubMed    


  140. XIE J, Jiang M, Li L
    Letter by Xie et al Regarding Article, "Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications".
    Circulation. 2019;140:e513-e514.
    PubMed    



  141. Correction to: Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
    Circulation. 2019;140:e543.
    PubMed    



  142. Correction to: Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications.
    Circulation. 2019;140:e544.
    PubMed    


  143. GRANDI SM, Platt RW
    Response by Grandi and Platt to Letter Regarding Article, "Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications".
    Circulation. 2019;140:e515-e516.
    PubMed    


  144. KHANNA A, Pequeno P, Gupta S, Thavendiranathan P, et al
    Increased Risk of All Cardiovascular Disease Subtypes Among Childhood Cancer Survivors: Population-Based Matched Cohort Study.
    Circulation. 2019 Aug 26. doi: 10.1161/CIRCULATIONAHA.119.041403.
    PubMed    


  145. VERMA S, Mazer CD, Yan AT, Mason T, et al
    Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
    Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.119.042375.
    PubMed     Abstract available


  146. OUCHI Y, Sasaki J, Arai H, Yokote K, et al
    Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial.
    Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.118.039415.
    PubMed     Abstract available


  147. ZHANG S, Zhuang X, Liao X
    Letter by Zhang et al Regarding Article, "Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study".
    Circulation. 2019;140:e329-e330.
    PubMed    


  148. AGHA G, Mendelson MM, Ward-Caviness CK, Joehanes R, et al
    Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease.
    Circulation. 2019;140:645-657.
    PubMed     Abstract available


  149. ARORA S, Rosamond WD, Caughey MC
    Response by Arora et al to Letter Regarding Article, "Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study".
    Circulation. 2019;140:e331-e332.
    PubMed    


  150. SHAKIBA M, Mansournia MA
    Letter by Shakiba and Mansournia Regarding Article, "Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015".
    Circulation. 2019;140:e325-e326.
    PubMed    


  151. ZEKI AL HAZZOURI A, Elfassy T, Glymour MM
    Response by Zeki Al Hazzouri et al to Letter Regarding Article, "Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015".
    Circulation. 2019;140:e327-e328.
    PubMed    


  152. LARSSON SC, Markus HS
    Genetic Liability to Insomnia and Cardiovascular Disease Risk.
    Circulation. 2019 Aug 19. doi: 10.1161/CIRCULATIONAHA.119.041830.
    PubMed    


  153. DEFILIPPIS AP, Chapman AR, Mills NL, de Lemos JA, et al
    Assessment and Treatment of Patients with Type 2 Myocardial Infarction and Acute Non-Ischemic Myocardial Injury.
    Circulation. 2019 Aug 16. doi: 10.1161/CIRCULATIONAHA.119.040631.
    PubMed     Abstract available


  154. THAN MP, Pickering JW, Sandoval Y, Shah ASV, et al
    Machine Learning to Predict the Likelihood of Acute Myocardial Infarction.
    Circulation. 2019 Aug 16. doi: 10.1161/CIRCULATIONAHA.119.041980.
    PubMed     Abstract available


  155. WANG W
    Letter by Wang Regarding Article, "Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation".
    Circulation. 2019;140:e290-e291.
    PubMed    


  156. CLELAND JGF, Pellicori P
    Myocardial Dysfunction and Coronary Artery Disease as Therapeutic Targets in Heart Failure.
    Circulation. 2019;140:538-541.
    PubMed    


  157. MAULER M, Hilgendorf I, Duerschmied D
    Response by Mauler et al to Letter Regarding Article, "Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation".
    Circulation. 2019;140:e292-e293.
    PubMed    


  158. AENGEVAEREN VL, Hopman MTE, Thompson PD, Bakker EA, et al
    Exercise-Induced Cardiac Troponin I Increase and Incident Mortality and Cardiovascular Events.
    Circulation. 2019 Aug 12. doi: 10.1161/CIRCULATIONAHA.119.041627.
    PubMed    


  159. FOO RS, Anene-Nzelu CG, Rosa-Garrido M, Vondriska TM, et al
    Dissecting Chromatin Architecture for Novel Cardiovascular Disease Targets.
    Circulation. 2019;140:446-448.
    PubMed    


  160. PACKER M
    Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
    Circulation. 2019;140:443-445.
    PubMed    


    July 2019
  161. FAN Q, Mao H, Angelini A, Coarfa C, et al
    Depletion of Endothelial Prolyl Hydroxylase Domain Protein 2 and 3 Promotes Cardiomyocyte Proliferation and Prevents Ventricular Failure Induced by Myocardial Infarction.
    Circulation. 2019;140:440-442.
    PubMed    


  162. FAN Q, Zhang R, Yan X
    Response by Fan et al to Letter Regarding Article, "Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration".
    Circulation. 2019;140:e179-e180.
    PubMed    


  163. TANDON A, de Ferranti SD
    Wearable Biosensors in Pediatric Cardiovascular Disease.
    Circulation. 2019;140:350-352.
    PubMed    


  164. LI Y, Shen Z, Yu XY
    Letter by Li et al Regarding Article, "Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration".
    Circulation. 2019;140:e177-e178.
    PubMed    


  165. BRILAKIS ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, et al
    Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.
    Circulation. 2019;140:420-433.
    PubMed     Abstract available


  166. BICK AG, Akwo E, Robinson-Cohen C, Lee K, et al
    Association of APOL1 Risk Alleles with Cardiovascular Disease in African Americans in the Million Veteran Program.
    Circulation. 2019 Jul 24. doi: 10.1161/CIRCULATIONAHA.118.036589.
    PubMed     Abstract available



  167. Correction to: Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Circulation. 2019;140:e171.
    PubMed    


  168. HE Z, Ding R, Liang C
    Letter by He et al Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e156-e157.
    PubMed    


  169. ZHU J, Peng X, Zheng Z
    Letter by Zhu et al Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e152-e153.
    PubMed    


  170. FUERNAU G, Thiele H
    Response by Fuernau and Thiele to Letters Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e158-e159.
    PubMed    



  171. Correction to: Cardiac Troponin to Guide the Use of Noninvasive Testing in Patients Ruled Out for Myocardial Infarction.
    Circulation. 2019;140:e162.
    PubMed    


  172. BENGUEDDACHE S, Bendjelid K
    Letter by Bengueddache and Bendjelid Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e154-e155.
    PubMed    


  173. KUEHN BM
    Community-Based Cardiovascular Interventions Gain Steam.
    Circulation. 2019;140:262-263.
    PubMed    


  174. MAHAFFEY KW, Jardine MJ, Bompoint S, Cannon CP, et al
    Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial.
    Circulation. 2019 Jul 11. doi: 10.1161/CIRCULATIONAHA.119.042007.
    PubMed     Abstract available


  175. WESTRA J, Andersen BK, Holm NR
    Letter by Westra et al Regarding Article, "Accuracy of Fractional Flow Reserve Derived From Coronary Angiography".
    Circulation. 2019;140:e94-e95.
    PubMed    


  176. FEARON WF, Kornowski R, De Bruyne B
    Response by Fearon et al to Letter Regarding Article, "Accuracy of Fractional Flow Reserve Derived From Coronary Angiography".
    Circulation. 2019;140:e96-e97.
    PubMed    


  177. BAYS HE
    Alirocumab, Decreased Mortality, Nominal Significance, P Values, Bayesian Statistics, and the Duplicity of Multiplicity.
    Circulation. 2019;140:113-116.
    PubMed    


  178. SIGWART U
    Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy: Is It Appropriate?
    Circulation. 2019;140:11-12.
    PubMed    


  179. BUENO H, Perez-Gomez B
    Global Rounds: Cardiovascular Health, Disease, and Care in Spain.
    Circulation. 2019;140:13-15.
    PubMed    


  180. TALEB I, Koliopoulou AG, Tandar A, McKellar SH, et al
    Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept.
    Circulation. 2019;140:98-100.
    PubMed    


    June 2019
  181. WELSH C, Celis-Morales CA, Brown R, Mackay DF, et al
    Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank.
    Circulation. 2019 Jun 20. doi: 10.1161/CIRCULATIONAHA.119.041149.
    PubMed     Abstract available


  182. KHALID N, Shlofmitz E, Waksman R
    Letter by Khalid et al Regarding Article, "Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction: A Pilot Study Using the Impella CP".
    Circulation. 2019;139:e1040-e1041.
    PubMed    



  183. Correction to: Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.
    Circulation. 2019;139:e1188.
    PubMed    


  184. DI VECE D, Citro R, Templin C
    Response by Di Vece et al to Letter Regarding Article, "Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome: Results From the International Takotsubo Registry".
    Circulation. 2019;139:e1044-e1045.
    PubMed    


  185. Y-HASSAN S
    Letter by Y-Hassan Regarding Article, "Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome: Results From the International Takotsubo Registry".
    Circulation. 2019;139:e1042-e1043.
    PubMed    


  186. WANG D, Yang X, Zhong H
    Letter by Wang et al Regarding Article, "Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".
    Circulation. 2019;139:e1033-e1034.
    PubMed    


  187. BANSAL SS, Ismahil MA, Goel M, Zhou G, et al
    Response by Bansal et al to Letter Regarding Article, "Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".
    Circulation. 2019;139:e1035-e1036.
    PubMed    


  188. BIKDELI B, Welsh JW, Akram Y, Punnanithinont N, et al
    Non-Inferiority Designed Cardiovascular Trials in Highest-Impact Journals: Main Findings, Methodological Quality and Time Trends.
    Circulation. 2019 Jun 10. doi: 10.1161/CIRCULATIONAHA.119.040214.
    PubMed     Abstract available


  189. ARNOLD SV, de Lemos JA, Rosenson RS, Ballantyne CM, et al
    Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOUL
    Circulation. 2019 Jun 7. doi: 10.1161/CIRCULATIONAHA.119.041730.
    PubMed     Abstract available


  190. ARAVANI D, Morris GE, Jones PD, Tattersall HK, et al
    HHIPL1, a Gene at the 14q32 Coronary Artery Disease Locus, Positively Regulates Hedgehog Signaling and Promotes Atherosclerosis.
    Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.041059.
    PubMed     Abstract available


  191. BRANCH KR, Probstfield JL, Eikelboom JW, Bosch J, et al
    Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609.
    PubMed     Abstract available


  192. OLDE RIKKERT MGM, Fernandes M
    Letter by Olde Rikkert and Fernandes Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1021-e1022.
    PubMed    


  193. BRESS AP, Muntner P, Moran AE
    Response by Bress et al to Letters Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1023-e1024.
    PubMed    


  194. RUEDA-OCHOA OL, Rizopoulos D, Kavousi M
    Letter by Rueda-Ochoa et al Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1019-e1020.
    PubMed    


  195. FEINSTEIN MJ, Hsue PY, Benjamin LA, Bloomfield GS, et al
    Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Jun 3:CIR0000000000000695. doi: 10.1161/CIR.0000000000000695.
    PubMed     Abstract available


    May 2019
  196. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Response by Mann et al to Letter Regarding Article, "Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial".
    Circulation. 2019;139:e1017-e1018.
    PubMed    


  197. XIE J, Jiang M, Li L
    Letter by Xie et al Regarding Article, "Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial".
    Circulation. 2019;139:e1015-e1016.
    PubMed    


  198. KONSTAM MA, Konstam AD
    Gun Violence and Cardiovascular Health.
    Circulation. 2019;139:2499-2501.
    PubMed    


  199. STEG PG, Szarek M, Bhatt DL, Bittner VA, et al
    Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038840.
    PubMed     Abstract available


  200. URBAN P, Mehran R, Colleran R, Angiolillo DJ, et al
    Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk.
    Circulation. 2019 May 22. doi: 10.1161/CIRCULATIONAHA.119.040167.
    PubMed     Abstract available


  201. KARAM N, Marijon E, Jouven X
    Letter by Karam et al Regarding Article, "Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction: Partners YOUNG-MI Registry".
    Circulation. 2019;139:e994-e995.
    PubMed    


  202. DEFILIPPIS EM, Singh A, Bhatt DL, Blankstein R, et al
    Response by DeFilippis et al to Letter Regarding Article, "Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction: Partners YOUNG-MI Registry".
    Circulation. 2019;139:e996.
    PubMed    


  203. KUEHN BM
    Sleep Duration Linked to Cardiovascular Disease.
    Circulation. 2019;139:2483-2484.
    PubMed    


  204. SANDERS TAB
    Omega-6 Fatty Acids and Cardiovascular Disease.
    Circulation. 2019;139:2437-2439.
    PubMed    


  205. NYSTROM T, Sartipy U, Contardi A, Lind M, et al
    Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction.
    Circulation. 2019;139:2380-2382.
    PubMed    


  206. BONELLO L, Laine M, Lemesle G
    Letter by Bonello et al Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".
    Circulation. 2019;139:e959-e960.
    PubMed    


  207. KOFOED KF, Kelbaek H, Engstrom T, Kober LV, et al
    Response by Kofoed et al to Letter Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".
    Circulation. 2019;139:e961-e962.
    PubMed    


  208. THOMAS RJ, Beatty AL, Beckie TM, Brewer LC, et al
    Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.
    Circulation. 2019 May 13:CIR0000000000000663. doi: 10.1161/CIR.0000000000000663.
    PubMed     Abstract available


  209. CAPPOLA AR, Desai AS, Medici M, Cooper LS, et al
    Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.
    Circulation. 2019 May 13. doi: 10.1161/CIRCULATIONAHA.118.036859.
    PubMed     Abstract available


  210. AGIRBASLI M, Aksoy A
    Letter by Agirbasli and Aksoy Regarding Article, "Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population".
    Circulation. 2019;139:e911-e912.
    PubMed    


  211. DOOSTI-IRANI A, Mansournia MA, Collins G
    Letter by Doosti-Irani et al Regarding Article, "Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population".
    Circulation. 2019;139:e909-e910.
    PubMed    


    April 2019
  212. RAVNSKOV U, Okuyama H, Sultan S
    Letter by Ravnskov et al Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longit
    Circulation. 2019;139:2188-2189.
    PubMed    


  213. ABDULLAH SM, Defina LF, Leonard D, Khera A, et al
    Response by Abdullah et al to Letters Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper
    Circulation. 2019;139:2192-2193.
    PubMed    


  214. KE C, Shen Y
    Letter by Ke and Shen Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudi
    Circulation. 2019;139:2190-2191.
    PubMed    


  215. GURBEL PA, Fox KAA, Tantry US, Ten Cate H, et al
    Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease.
    Circulation. 2019;139:2170-2185.
    PubMed     Abstract available


  216. BANGALORE S
    Response by Bangalore to Letter Regarding Article, "Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials".
    Circulation. 2019;139:2083-2084.
    PubMed    


  217. ROMAGUERA R, Gomez-Lara J, Gomez-Hospital JA
    Letter by Romaguera et al Regarding Article, "Newer Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials".
    Circulation. 2019;139:2081-2082.
    PubMed    


  218. SANO M, Goto S
    Possible Mechanism of Hematocrit Elevation by Sodium Glucose Cotransporter 2 Inhibitors and Associated Beneficial Renal and Cardiovascular Effects.
    Circulation. 2019;139:1985-1987.
    PubMed    


  219. KEY TJ, Appleby PN, Bradbury KE, Sweeting M, et al
    Consumption of Meat, Fish, Dairy Products, Eggs and Risk of Ischemic Heart Disease: A Prospective Study of 7198 Incident Cases Among 409,885 Participants in the Pan-European EPIC Cohort.
    Circulation. 2019 Apr 22. doi: 10.1161/CIRCULATIONAHA.118.038813.
    PubMed     Abstract available


  220. PUSKAS JD, Gaudino M, Taggart DP
    Experience Is Crucial in Off-Pump Coronary Artery Bypass Grafting.
    Circulation. 2019;139:1872-1875.
    PubMed    


  221. PAHIGIANNIS K, Thompson-Paul AM, Barfield W, Ochiai E, et al
    Progress Toward Improved Cardiovascular Health in the United States.
    Circulation. 2019;139:1957-1973.
    PubMed     Abstract available


  222. LARSEN TR, Padala SK, Ellenbogen KA
    Resolution of Bundle Branch Block.
    Circulation. 2019;139:1974-1976.
    PubMed    


  223. WRIGHT AK, Kontopantelis E, Emsley R, Buchan IE, et al
    Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039100.
    PubMed     Abstract available


  224. MARKLUND M, Wu JHY, Imamura F, Del Gobbo LC, et al
    Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies.
    Circulation. 2019 Apr 11. doi: 10.1161/CIRCULATIONAHA.118.038908.
    PubMed     Abstract available


  225. GUASCH-FERRE M, Satija A, Blondin SA, Janiszewski M, et al
    Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors.
    Circulation. 2019;139:1828-1845.
    PubMed     Abstract available


  226. GILCHRIST SC, Barac A, Ades PA, Alfano CM, et al
    Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Apr 8:CIR0000000000000679. doi: 10.1161/CIR.0000000000000679.
    PubMed     Abstract available


  227. SATTAR N, Rawshani A, Franzen S, Rawshani A, et al
    Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks Findings From the Swedish National Diabetes Registry.
    Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.037885.
    PubMed    


  228. HUANG S, Li X, Zheng H, Si X, et al
    Loss of Super-Enhancer-Regulated CircRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice.
    Circulation. 2019 Apr 5. doi: 10.1161/CIRCULATIONAHA.118.038361.
    PubMed     Abstract available


  229. ERLINGE D
    Cangrelor for ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2019;139:1671-1673.
    PubMed    


  230. MILLS NL, Omland T
    Cardiac Troponin to Guide the Use of Noninvasive Testing in Patients Ruled Out for Myocardial Infarction.
    Circulation. 2019;139:1655-1657.
    PubMed    


  231. LOW WANG CC, Everett BM, Burman KD, Wilson PWF, et al
    Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?
    Circulation. 2019;139:1741-1743.
    PubMed    



  232. Correction to: High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD).
    Circulation. 2019;139:e836.
    PubMed    


  233. BRILAKIS ES, Mashayekhi K, Burke MN
    How DECISION-CTO Can Help Guide the Decision to Perform Chronic Total Occlusion Percutaneous Coronary Intervention.
    Circulation. 2019;139:1684-1687.
    PubMed    


  234. SLIWA K, Ntusi N
    Battling Cardiovascular Diseases in a Perfect Storm.
    Circulation. 2019;139:1658-1660.
    PubMed    


  235. SANDOVAL Y, Smith SW, Sexter A, Gunsolus IL, et al
    Clinical Features and Outcomes of Emergency Department Patients With High-Sensitivity Cardiac Troponin I Concentrations Within Sex-Specific Reference Intervals.
    Circulation. 2019;139:1753-1755.
    PubMed    


  236. KOMATSU Y, Hocini M, Nogami A, Maury P, et al
    Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction: A Multicenter Study.
    Circulation. 2019 Apr 1. doi: 10.1161/CIRCULATIONAHA.118.037997.
    PubMed     Abstract available


    March 2019
  237. TAMIS-HOLLAND JE, Jneid H, Reynolds HR, Agewall S, et al
    Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Mar 27:CIR0000000000000670. doi: 10.1161/CIR.0000000000000670.
    PubMed     Abstract available


  238. NIELSEN R, Moller N, Gormsen LC, Tolbod LP, et al
    Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Circulation. 2019 Mar 19. doi: 10.1161/CIRCULATIONAHA.118.036459.
    PubMed     Abstract available


  239. PLAYAN-ESCRIBANO J, Martinez-Losas P, Cobos-Gil MA
    Electrocardiographic Changes After Angioplasty of the Left Anterior Descending Coronary Artery.
    Circulation. 2019;139:1550-1553.
    PubMed    


  240. YANNOPOULOS D, Bartos JA, Aufderheide TP, Callaway CW, et al
    The Evolving Role of the Cardiac Catheterization Laboratory in the Management of Patients With Out-of-Hospital Cardiac Arrest: A Scientific Statement From the American Heart Association.
    Circulation. 2019;139:e530-e552.
    PubMed     Abstract available


  241. ZLATANOVA I, Pinto C, Bonnin P, Mathieu JRR, et al
    Iron Regulator Hepcidin Impairs Macrophage-Dependent Cardiac Repair After Injury.
    Circulation. 2019;139:1530-1547.
    PubMed     Abstract available


  242. FURTADO RHM, Bonaca MP, Raz I, Zelniker TA, et al
    Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction: A Sub-analysis From DECLARE TIMI-58 Trial.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039996.
    PubMed     Abstract available


  243. BONSU J, Charles L, Guha A, Awan F, et al
    Representation of Patients with Cardiovascular Disease in Pivotal Cancer Clinical Trials.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.118.039180.
    PubMed     Abstract available


  244. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019 Mar 17:CIR0000000000000678. doi: 10.1161/CIR.0000000000000678.
    PubMed    


  245. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary.
    Circulation. 2019 Mar 17:CIR0000000000000677. doi: 10.1161/CIR.0000000000000677.
    PubMed    


  246. BITTNER VA
    The New 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040625.
    PubMed     Abstract available


  247. PICKERING JW
    The Need to Improve Derivation and Description of Algorithms to Rule-Out Patients With Possible Myocardial Infarction.
    Circulation. 2019;139:1351-1353.
    PubMed    


  248. LONG M, Ye Z, Li L
    Letter by Long et al Regarding Article, "Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease".
    Circulation. 2019;139:1467-1468.
    PubMed    


  249. KUEHN BM
    Large Trial Finds Yoga Boosts Quality of Life and Return to Activity and Adds to Emerging Evidence for Rehabilitation Alternatives.
    Circulation. 2019;139:1451-1453.
    PubMed    


  250. BHATNAGAR A, Maziak W, Eissenberg T, Ward KD, et al
    Water Pipe (Hookah) Smoking and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Mar 8:CIR0000000000000671. doi: 10.1161/CIR.0000000000000671.
    PubMed     Abstract available


  251. KUWABARA M
    Letter by Kuwabara Regarding Article, "Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study".
    Circulation. 2019;139:1348-1349.
    PubMed    


  252. DORING Y, van der Vorst EPC, Duchene J, Jansen Y, et al
    CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease.
    Circulation. 2019;139:1338-1340.
    PubMed    


  253. POULIDAKIS E, Spaulding C
    Cardiac Assist Devices in Cardiogenic Shock.
    Circulation. 2019;139:1259-1261.
    PubMed    


    February 2019
  254. BURROUGHS-PENA MS, Mbassa RS, Slopen NB, Williams DR, et al
    Cumulative Psychosocial Stress and Ideal Cardiovascular Health in Older Women: Data by Race/Ethnicity.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.033915.
    PubMed     Abstract available


  255. SAHA P, Potiny P, Rigdon J, Morello M, et al
    Substantial Cardiovascular Morbidity in Adults with Lower-Complexity Congenital Heart Disease.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.037064.
    PubMed     Abstract available


  256. LEE SW, Lee PH, Ahn JM, Park DW, et al
    Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.031313.
    PubMed     Abstract available


  257. MEHTA A, Mandawat A
    Letter by Mehta and Mandawat Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease".
    Circulation. 2019;139:1243-1244.
    PubMed    



  258. Correction to: Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:e55.
    PubMed    


  259. NAFEE T, Gibson CM, Yee MK, Kerneis M, et al
    Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
    Circulation. 2019;139:1234-1236.
    PubMed    


  260. SIMES J, Kirby A, Tonkin A
    Response by Simes et al to Letter Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease".
    Circulation. 2019;139:1245-1246.
    PubMed    


  261. DIVANJI P, Deo R, Harris I
    Coronary Arteries and the Cell Count.
    Circulation. 2019;139:1228-1233.
    PubMed    


  262. RAWSHANI A, Rawshani A, Sattar N, Franzen S, et al
    Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes.
    Circulation. 2019 Feb 25. doi: 10.1161/CIRCULATIONAHA.118.037454.
    PubMed     Abstract available


  263. DE FERRANTI SD, Steinberger J, Ameduri R, Baker A, et al
    Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Feb 25:CIR0000000000000618. doi: 10.1161/CIR.0000000000000618.
    PubMed     Abstract available


  264. ZELNIKER TA, Wiviott SD, Raz I, Im K, et al
    Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of
    Circulation. 2019 Feb 21. doi: 10.1161/CIRCULATIONAHA.118.038868.
    PubMed     Abstract available


  265. VACCARINO V
    Myocardial Infarction in Young Women.
    Circulation. 2019;139:1057-1059.
    PubMed    


  266. PETERS SAE, Muntner P, Woodward M
    Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Circulation. 2019;139:1025-1035.
    PubMed     Abstract available


  267. BARISH R, Lynce F, Unger K, Barac A, et al
    Management of Cardiovascular Disease in Women With Breast Cancer.
    Circulation. 2019;139:1110-1120.
    PubMed     Abstract available


  268. BUI QM, Daniels LB
    A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women.
    Circulation. 2019;139:1094-1101.
    PubMed     Abstract available


  269. KALINOWSKI J, Taylor JY, Spruill TM
    Why Are Young Black Women at High Risk for Cardiovascular Disease?
    Circulation. 2019;139:1003-1004.
    PubMed    


  270. OUYANG D, Harrington RA, Rodriguez F
    Association Between Female Corresponding Authors and Female Co-Authors in Top Contemporary Cardiovascular Medicine Journals.
    Circulation. 2019;139:1127-1129.
    PubMed    


  271. HAN JK, Yano EM, Watson KE, Ebrahimi R, et al
    Cardiovascular Care in Women Veterans.
    Circulation. 2019;139:1102-1109.
    PubMed     Abstract available


  272. GRANDI SM, Filion KB, Yoon S, Ayele HT, et al
    Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications.
    Circulation. 2019;139:1069-1079.
    PubMed     Abstract available


  273. BELLETTIERE J, LaMonte MJ, Evenson KR, Rillamas-Sun E, et al
    Sedentary behavior and cardiovascular disease in older women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study.
    Circulation. 2019;139:1036-1046.
    PubMed     Abstract available


  274. HOCHMAN JS, Rutherford JD
    Clinical Studies in Myocardial Revascularization.
    Circulation. 2019;139:1007-1011.
    PubMed    


  275. HAUKILAHTI MAE, Holmstrom L, Vahatalo J, Kentta T, et al
    Sudden Cardiac Death in Women.
    Circulation. 2019;139:1012-1021.
    PubMed     Abstract available


  276. NOTA NM, Wiepjes CM, de Blok CJM, Gooren LJG, et al
    The Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy: Results from a Large Cohort Study.
    Circulation. 2019 Feb 18. doi: 10.1161/CIRCULATIONAHA.118.038584.
    PubMed     Abstract available


  277. BENSCHOP L, Schalekamp-Timmermans S, Broere-Brown ZA, Roeters van Lennep JE, et al
    Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.
    Circulation. 2019 Feb 14. doi: 10.1161/CIRCULATIONAHA.118.036632.
    PubMed     Abstract available


  278. RABINOVICH-NIKITIN I, Lieberman B, Martino TA, Kirshenbaum LA, et al
    Circadian-Regulated Cell Death in Cardiovascular Diseases.
    Circulation. 2019;139:965-980.
    PubMed     Abstract available


  279. MORROW DA, Wiviott SD
    Classification of Deaths in Cardiovascular Outcomes Trials.
    Circulation. 2019;139:874-876.
    PubMed    


  280. SPATZ ES, Herrin J
    Cardiovascular Outcomes in the Wake of Financial Uncertainty.
    Circulation. 2019;139:860-862.
    PubMed    


  281. MORDI IR, Pearson ER, Palmer CNA, Doney ASF, et al
    Differential Association of Genetic Risk of Coronary Artery Disease With Development of Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Circulation. 2019;139:986-988.
    PubMed    


  282. LEE JM, Choi KH, Park J, Hwang D, et al
    Physiological and Clinical Assessment of Resting Physiological Indexes.
    Circulation. 2019;139:889-900.
    PubMed     Abstract available


  283. DIEGELER A, Borgermann J, Kappert U, Hilker M, et al
    Five-Year Outcome after Off-Pump or On-Pump Coronary Artery Bypass Grafting in Elderly Patients.
    Circulation. 2019 Feb 8. doi: 10.1161/CIRCULATIONAHA.118.035857.
    PubMed     Abstract available


  284. LI DJ, Chen XP, Zhang XB
    Letter by Li et al Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:839-840.
    PubMed    


  285. BRINTON TJ, Ali ZA, Hill JM, Meredith IT, et al
    Feasibility of Shockwave Coronary Intravascular Lithotripsy for the Treatment of Calcified Coronary Stenoses.
    Circulation. 2019;139:834-836.
    PubMed    


  286. SU Q, Li Q
    Letter by Su and Li Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:837-838.
    PubMed    


  287. PETRIE JR, Sattar N
    Excess Cardiovascular Risk in Type 1 Diabetes Mellitus.
    Circulation. 2019;139:744-747.
    PubMed    


  288. UDDIN SMI, Dardari Z, Blaha MJ
    Response by Uddin et al to Letters Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:841-842.
    PubMed    


    January 2019
  289. LIM CC, Hayes RB, Ahn J, Shao Y, et al
    Mediterranean Diet and the Association Between Air Pollution and Cardiovascular Disease Mortality Risk.
    Circulation. 2019 Jan 31. doi: 10.1161/CIRCULATIONAHA.118.035742.
    PubMed     Abstract available


  290. VISKIN S, Chorin E, Viskin D, Hochstadt A, et al
    Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients with Coronary Heart Disease.
    Circulation. 2019 Jan 30. doi: 10.1161/CIRCULATIONAHA.118.038036.
    PubMed     Abstract available


  291. WANG Y, Dembowsky K, Chevalier E, Stuve P, et al
    C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
    Circulation. 2019 Jan 30. doi: 10.1161/CIRCULATIONAHA.118.036053.
    PubMed     Abstract available


  292. MCMILLAN A, Hazen SL
    Gut Microbiota Involvement in Ventricular Remodeling Post-Myocardial Infarction.
    Circulation. 2019;139:660-662.
    PubMed    


  293. HAKEEM A, Uretsky BF
    Role of Postintervention Fractional Flow Reserve to Improve Procedural and Clinical Outcomes.
    Circulation. 2019;139:694-706.
    PubMed     Abstract available


  294. TANG TWH, Chen HC, Chen CY, Yen CYT, et al
    Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair.
    Circulation. 2019;139:647-659.
    PubMed     Abstract available


  295. MCCLELLAN M, Brown N, Califf RM, Warner JJ, et al
    Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2019 Jan 24:CIR0000000000000652. doi: 10.1161/CIR.0000000000000652.
    PubMed     Abstract available


  296. PARE G, Caku A, McQueen M, Anand SS, et al
    Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among Seven Ethnic Groups.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.034311.
    PubMed     Abstract available


  297. SANDOVAL Y, Jaffe AS, Apple FS
    Letter by Sandoval et al Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction".
    Circulation. 2019;139:562-563.
    PubMed    


  298. MCCORD J, Newby LK, deFilippi CR
    Response by McCord et al to Letter Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Inf
    Circulation. 2019;139:564-565.
    PubMed    


  299. HAO Y, Liu J, Liu J, Yang N, et al
    Sex Differences in In-hospital Management and Outcomes of Patients with Acute Coronary Syndrome: Findings from the Improving Care for Cardiovascular Disease in China (CCC) Project.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.037655.
    PubMed     Abstract available


  300. SHARMA M, Hart RG, Connolly SJ, Bosch J, et al
    Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.035864.
    PubMed     Abstract available


  301. ATIENZA F, Marquez MF, Sanchez-Quintana D
    Letter by Atienza et al Regarding Article, "Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now".
    Circulation. 2019;139:566-567.
    PubMed    


  302. THIENE G, Saffitz JE
    Response by Thiene and Saffitz to Letter Regarding Article, "Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now".
    Circulation. 2019;139:568-569.
    PubMed    


  303. MATHIYALAGAN P, Adamiak M, Mayourian J, Sassi Y, et al
    FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.
    Circulation. 2019;139:518-532.
    PubMed     Abstract available



  304. Correction to: Waiting for Godot: Engaging in Discussions About Depression Care in Patients With Acute Myocardial Infarction While Waiting for a Definitive Trial That Never Appears.
    Circulation. 2019;139:e7.
    PubMed    



  305. Correction to: Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock.
    Circulation. 2019;139:e9.
    PubMed    


  306. FIGTREE GA, Radholm K, Neal B
    Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:418-419.
    PubMed    


  307. KOH KK
    Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:416-417.
    PubMed    


  308. PATEL MR
    Percutaneous Support Devices for Percutaneous Coronary Intervention.
    Circulation. 2019;139:347-350.
    PubMed    


  309. DI VECE D, Citro R, Cammann VL, Kato K, et al
    Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome.
    Circulation. 2019;139:413-415.
    PubMed    


  310. FRANCHI F, Rollini F, Rivas A, Wali M, et al
    Platelet Inhibition with Cangrelor and Crushed Ticagrelor in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study.
    Circulation. 2019 Jan 11. doi: 10.1161/CIRCULATIONAHA.118.038317.
    PubMed     Abstract available



  311. Correction to: Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2019;139:e2.
    PubMed    


  312. NASSIF ME, Kosiborod M
    Response by Nassif and Kosiborod to Letter Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes".
    Circulation. 2019;139:305-306.
    PubMed    


  313. POTIER L, Roussel R
    Letter by Potier and Roussel Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes".
    Circulation. 2019;139:303-304.
    PubMed    


  314. BANSAL SS, Ismahil MA, Goel M, Zhou G, et al
    Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Circulation. 2019;139:206-221.
    PubMed     Abstract available


  315. ELFASSY T, Swift SL, Glymour MM, Calonico S, et al
    Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015.
    Circulation. 2019 Jan 7. doi: 10.1161/CIRCULATIONAHA.118.035521.
    PubMed    


  316. VANHAVERBEKE M, Bogaerts K, Sinnaeve PR, Janssens L, et al
    Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:137-139.
    PubMed    


  317. OEMRAWSINGH RM, Akkerhuis KM, de Mulder M, Umans VA, et al
    High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.
    Circulation. 2019;139:134-136.
    PubMed    


  318. PRABHAKARAN D, Jaacks LM
    Reflections From India on Scaling Up Risk Factor Control for Cardiovascular Diseases to Reach 1 Billion Adults.
    Circulation. 2019;139:4-6.
    PubMed    


  319. BRESS AP, Colantonio LD, Cooper RS, Kramer H, et al
    Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Circulation. 2019;139:24-36.
    PubMed     Abstract available


  320. ROZEMEIJER R, Stein M, Voskuil M, van den Bor R, et al
    Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
    Circulation. 2019;139:67-77.
    PubMed     Abstract available


    December 2018
  321. VERMA S, Poulter NR, Bhatt DL, Bain SC, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
    Circulation. 2018;138:2884-2894.
    PubMed     Abstract available


  322. FRIEDMAN DJ, Al-Khatib SM
    Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2972-2973.
    PubMed    


  323. BROUWER TF, Burke MC, Knops RE
    Letter by Brouwer et al Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2970-2971.
    PubMed    


  324. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Circulation. 2018;138:2908-2918.
    PubMed     Abstract available


  325. DEFILIPPIS EM, Singh A, Gupta A, Ayuba G, et al
    Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction.
    Circulation. 2018;138:2855-2857.
    PubMed    


  326. KOFOED KF, Kelbaek H, Hansen PR, Torp-Pedersen C, et al
    Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    Circulation. 2018;138:2741-2750.
    PubMed     Abstract available


  327. JOLLY SS, Mehta SR
    Timing of Intervention in Non-ST Elevation Acute Coronary Syndromes.
    Circulation. 2018;138:2751-2753.
    PubMed    



  328. Correction to: Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial.
    Circulation. 2018;138:e750.
    PubMed    


  329. JERNBERG T, Lindahl B, Alfredsson J, Berglund E, et al
    Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
    Circulation. 2018;138:2754-2762.
    PubMed     Abstract available


  330. PENCINA MJ, Navar AM, Wojdyla D, Sanchez RJ, et al
    Quantifying Importance of Major Risk Factors for Coronary Heart Disease.
    Circulation. 2018 Dec 7. doi: 10.1161/CIRCULATIONAHA.117.031855.
    PubMed     Abstract available


  331. FITCHETT D, Inzucchi SE, Cannon CP, McGuire DK, et al
    Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
    Circulation. 2018 Dec 6. doi: 10.1161/CIRCULATIONAHA.118.037778.
    PubMed     Abstract available


  332. SCHRAGE B, Ibrahim K, Loehn T, Werner N, et al
    Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.036614.
    PubMed     Abstract available


  333. TSUTSUMI K, Tsukahara K
    Is The Diagnosis ST-Segment Elevation or Non-ST-Segment Elevation Myocardial Infarction?
    Circulation. 2018;138:2715-2717.
    PubMed    


  334. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2724-2725.
    PubMed    


  335. KIMURA T, Iimuro S, Taguchi I, Iwata H, et al
    Response by Kimura et al to Letters Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2728-2729.
    PubMed    


  336. GONG L, Cao Y, Yang G
    Letter by Gong et al Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2726-2727.
    PubMed    


  337. DUFF JP, Topjian A, Berg MD, Chan M, et al
    2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2018;138:e731-e739.
    PubMed     Abstract available


  338. SOAR J, Donnino MW, Maconochie I, Aickin R, et al
    2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2018;138:e714-e730.
    PubMed     Abstract available


  339. PANCHAL AR, Berg KM, Kudenchuk PJ, Del Rios M, et al
    2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation an
    Circulation. 2018;138:e740-e749.
    PubMed     Abstract available


  340. KIM MK, Han K, Park YM, Kwon HS, et al
    Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Circulation. 2018;138:2627-2637.
    PubMed     Abstract available


  341. BARTOLOMAEUS H, Balogh A, Yakoub M, Homann S, et al
    The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage.
    Circulation. 2018 Dec 4. doi: 10.1161/CIRCULATIONAHA.118.036652.
    PubMed     Abstract available


    November 2018
  342. O'DONOGHUE ML, Fazio S, Giugliano RP, Stroes ESG, et al
    Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial.
    Circulation. 2018 Nov 30. doi: 10.1161/CIRCULATIONAHA.118.037184.
    PubMed     Abstract available


  343. MENTZ RJ, Thompson VP, Aguilar D, Choi J, et al
    Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease.
    Circulation. 2018;138:2576-2578.
    PubMed    


  344. CAO DJ
    Macrophages in Cardiovascular Homeostasis and Disease.
    Circulation. 2018;138:2452-2455.
    PubMed    


  345. AMEGAH AK
    Tackling the Growing Burden of Cardiovascular Diseases in Sub-Saharan Africa.
    Circulation. 2018;138:2449-2451.
    PubMed    


  346. SOUSA GR, Pober D, Galderisi A, Lv H, et al
    Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus: A DCCT/EDIC Cohort-Based Study.
    Circulation. 2018 Nov 26. doi: 10.1161/CIRCULATIONAHA.118.036068.
    PubMed     Abstract available


  347. BUDOFF MJ, Lutz SM, Kinney GL, Young KA, et al
    Coronary Artery Calcium on Noncontrast Thoracic Computerized Tomography Scans and All-Cause Mortality.
    Circulation. 2018;138:2437-2438.
    PubMed    


  348. ABDULLAH SM, Defina LF, Leonard D, Barlow CE, et al
    Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Circulation. 2018;138:2315-2325.
    PubMed     Abstract available


  349. GUNADASA-ROHLING M, Masters M, Maguire ML, Smart SC, et al
    Magnetic Resonance Imaging of the Regenerating Neonatal Mouse Heart.
    Circulation. 2018;138:2439-2441.
    PubMed    


  350. JHA AK
    Letter by Jha Regarding Article, "High-Target Versus Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients: A Randomized Controlled Trial".
    Circulation. 2018;138:2443-2444.
    PubMed    


  351. WADE KH, Chiesa ST, Hughes AD, Chaturvedi N, et al
    Assessing the causal role of body mass index on cardiovascular health in young adults: Mendelian randomization and recall-by-genotype analyses.
    Circulation. 2018;138:2187-2201.
    PubMed     Abstract available



  352. Correction to: Fourth Universal Definition of Myocardial Infarction (2018).
    Circulation. 2018;138:e652.
    PubMed    


  353. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth Universal Definition of Myocardial Infarction (2018).
    Circulation. 2018;138:e618-e651.
    PubMed    


  354. KATZ S, Smilowitz NR, Hochman JS
    Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038279.
    PubMed     Abstract available


  355. KHERA AV, Chaffin M, Zekavat SM, Collins RL, et al
    Whole Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized with Early-Onset Myocardial Infarction.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035658.
    PubMed     Abstract available


  356. KAPUR NK, Alkhouli M, DeMartini T, Faraz H, et al
    Unloading the Left Ventricle Before Reperfusion in Patients with Anterior ST-Segment Elevation Myocardial Infarction: A Pilot Study Using the Impella CP((R)).
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038269.
    PubMed     Abstract available


  357. ARORA S, Stouffer GAR, Kucharska-Newton A, Qamar A, et al
    Twenty Year Trends and Sex Differences in Young Adults Hospitalized with Acute Myocardial Infarction: The ARIC Community Surveillance Study.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.037137.
    PubMed     Abstract available


  358. THIELE H, Zeymer U, Thelemann N, Neumann FJ, et al
    Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038201.
    PubMed     Abstract available


  359. BANGALORE S
    The Elusive Late Benefit of Biodegradable Polymer Drug Eluting Stents.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038378.
    PubMed     Abstract available


  360. KUFNER S, Joner M, Thannheimer A, Hoppmann P, et al
    Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease: Results From the ISAR-TEST 4 Randomized Trial.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038065.
    PubMed     Abstract available


  361. MCGUIRE DK, Alexander JH, Johansen OE, Perkovic V, et al
    Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038352.
    PubMed     Abstract available


  362. LLOYD-JONES DM, Braun LT, Ndumele CE, Smith SC Jr, et al
    Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Circulation. 2018 Nov 10:CIR0000000000000638. doi: 10.1161/CIR.0000000000000638.
    PubMed     Abstract available


  363. ALASHI A, Lang R, Seballos R, Feinleib S, et al
    Dilation of the Proximal Thoracic Aorta in an Asymptomatic Primary Prevention Population Undergoing Noncontrast Chest Computed Tomography.
    Circulation. 2018 Nov 10. doi: 10.1161/CIRCULATIONAHA.118.036191.
    PubMed     Abstract available


  364. VON BORNSTADT D, Wang H, Paulsen MJ, Goldstone AB, et al
    Rapid Self-Assembly of Bioengineered Cardiovascular Bypass Grafts From Scaffold-Stabilized, Tubular Bilevel Cell Sheets.
    Circulation. 2018;138:2130-2144.
    PubMed     Abstract available


  365. ROCHA RV, Tam DY, Karkhanis R, Nedadur R, et al
    Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.
    Circulation. 2018;138:2081-2090.
    PubMed     Abstract available


  366. DOMANSKI MJ, Farkouh ME
    Optimal Treatment of Patients With Left Ventricular Dysfunction and Severe Coronary Artery Disease.
    Circulation. 2018;138:2079-2080.
    PubMed    


  367. RUEL M, Gardner TJ
    Introduction to the 2018 Cardiovascular Surgery-Themed Issue.
    Circulation. 2018;138:2075.
    PubMed    


  368. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay.
    Circulation. 2018 Nov 6:CIR0000000000000628. doi: 10.1161/CIR.0000000000000628.
    PubMed    


    October 2018
  369. VIGEN R, Kutscher P, Fernandez F, Yu A, et al
    Evaluation of a Novel Rule-Out Myocardial Infarction Protocol Incorporating High-Sensitivity Troponin T in a US Hospital.
    Circulation. 2018;138:2061-2063.
    PubMed    


  370. VAN LEEUWEN MAH, van der Hoeven NW, Janssens GN, Everaars H, et al
    Evaluation of Microvascular Injury in Revascularized Patients with ST Elevation Myocardial Infarction Treated with Ticagrelor versus Prasugrel: The REDUCE-MVI Trial.
    Circulation. 2018 Oct 30. doi: 10.1161/CIRCULATIONAHA.118.035931.
    PubMed     Abstract available


  371. MATSUMOTO J, Takada S, Kinugawa S, Furihata T, et al
    Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.
    Circulation. 2018;138:2064-2066.
    PubMed    


  372. MAULER M, Herr N, Schoenichen C, Witsch T, et al
    Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
    Circulation. 2018 Oct 25. doi: 10.1161/CIRCULATIONAHA.118.033942.
    PubMed     Abstract available


  373. INZUCCHI SE, Kosiborod M, Fitchett D, Wanner C, et al
    Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control.
    Circulation. 2018;138:1904-1907.
    PubMed    


  374. DONZELLI A, Schivalocchi A, Giudicatti G
    Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Effica
    Circulation. 2018;138:1912-1913.
    PubMed    


  375. KOH KK
    Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy Internat
    Circulation. 2018;138:1914-1915.
    PubMed    


  376. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    PubMed     Abstract available


  377. NISHI T, Piroth Z, De Bruyne B, Jagic N, et al
    Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
    Circulation. 2018;138:1797-1804.
    PubMed     Abstract available


  378. NICCOLI G, Montone RA, Sabato V, Crea F, et al
    Role of Allergic Inflammatory Cells in Coronary Artery Disease.
    Circulation. 2018;138:1736-1748.
    PubMed     Abstract available


  379. CHAPMAN AR, Hesse K, Andrews J, Ken Lee K, et al
    High-Sensitivity Cardiac Troponin I and Clinical Risk Scores in Patients With Suspected Acute Coronary Syndrome.
    Circulation. 2018;138:1654-1665.
    PubMed     Abstract available


  380. VAKAMUDI S, Jellis C, Mick S, Wu Y, et al
    Sex Differences in the Etiology of Surgical Mitral Valve Disease.
    Circulation. 2018;138:1749-1751.
    PubMed    


  381. JAMES M, Manns B
    Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease.
    Circulation. 2018;138:1515-1518.
    PubMed    


  382. VERMA S, Leiter LA, Mazer CD, Bain SC, et al
    Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
    Circulation. 2018;138:1605-1607.
    PubMed    


  383. CLAGGETT B, Lachin JM, Hantel S, Fitchett D, et al
    Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.
    Circulation. 2018;138:1599-1601.
    PubMed    


  384. BONELLO L, Angiolillo DJ, Aradi D, Sibbing D, et al
    P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes.
    Circulation. 2018;138:1582-1596.
    PubMed     Abstract available


  385. DAI Y, Song J, Li W, Yang T, et al
    RhoE Fine-Tunes Inflammatory Response in Myocardial Infarction.
    Circulation. 2018 Oct 5. doi: 10.1161/CIRCULATIONAHA.118.033700.
    PubMed     Abstract available


  386. LINDOW T, Warren S, Pahlm O
    Two Patients With Inferior ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2018;138:1481-1484.
    PubMed    


  387. KASKI JC, Crea F, Gersh BJ, Camici PG, et al
    Reappraisal of Ischemic Heart Disease.
    Circulation. 2018;138:1463-1480.
    PubMed     Abstract available


  388. NEELAND IJ, Poirier P, Despres JP
    Response by Neeland et al to Letter Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
    Circulation. 2018;138:1496-1497.
    PubMed    


  389. KAHN HS
    Letter by Kahn Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
    Circulation. 2018;138:1494-1495.
    PubMed    


    September 2018
  390. FAN Q, Tao R, Zhang H, Xie H, et al
    Dectin-1 Contributes to Myocardial Ischemia-Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration.
    Circulation. 2018 Sep 27. doi: 10.1161/CIRCULATIONAHA.118.036044.
    PubMed     Abstract available


  391. ROLLINI F, Franchi F
    Standard- and Low-Dose Ticagrelor After Percutaneous Coronary Intervention.
    Circulation. 2018;138:1301-1303.
    PubMed    


  392. GIMPEL D, Ray M
    Time to Get a @Handle on Twitter and Cardiovascular Medicine.
    Circulation. 2018;138:1285-1286.
    PubMed    


  393. KUEHN BM
    Boosting Women's Participation in Cardiovascular Trials.
    Circulation. 2018;138:1366-1367.
    PubMed    


  394. LEMESLE G
    Aspirin on Top of Anticoagulation in Patients with Concomitant Stable Coronary Artery Disease and Atrial Fibrillation: No Clear Answer Yet.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037440.
    PubMed    


  395. MATSUMURA-NAKANO Y, Shizuta S, Komasa A, Morimoto T, et al
    An Open-Label Randomized Trial Comparing Oral Anticoagulation with and without Single Antiplatelet Therapy in Patients with Atrial Fibrillation and Stable Coronary Artery Disease Beyond One Year after Coronary Stent Implantation: The OAC-ALONE Study.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.036768.
    PubMed     Abstract available


  396. FEARON WF, Achenbach S, Engstrom T, Assali A, et al
    Accuracy of Fractional Flow Reserve Derived From Coronary Angiography.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037350.
    PubMed     Abstract available


  397. PAPAFAKLIS MI, Baumbach A
    From Lumenogram to "Functional Angiography" and the Evolution of Virtual FFR: Has the Time Come for Outcome-Based Trials?
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037528.
    PubMed    


  398. RODEN DM
    Growing Pains in Cardiovascular Genetics.
    Circulation. 2018;138:1206-1209.
    PubMed    


  399. FANAROFF AC, Zakroysky P, Wojdyla D, Kaltenbach LA, et al
    Relationship Between Operator Volume and Long-Term Outcomes after Percutaneous Coronary Intervention: A Report from the NCDR CathPCI Registry.
    Circulation. 2018 Sep 12. doi: 10.1161/CIRCULATIONAHA.117.033325.
    PubMed     Abstract available


  400. CHAPMAN AR, Mills NL
    Response To Letter Regarding Article "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
    Circulation. 2018;138:1178.
    PubMed    


  401. MADIAS JE
    Letter by Madias Regarding Article, "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
    Circulation. 2018;138:1176-1177.
    PubMed    


  402. WHITE WB
    Gout, Xanthine Oxidase Inhibition, and Cardiovascular Outcomes.
    Circulation. 2018;138:1127-1129.
    PubMed    


  403. HSUE PY, Waters DD
    Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor.
    Circulation. 2018;138:1113-1115.
    PubMed    


  404. WENGER NK, Lorell BH, Bairey Merz CN
    Recent Legislation, Public Policy Changes, and Women's Cardiovascular Health.
    Circulation. 2018;138:1082-1084.
    PubMed    


  405. YASUDA S, Miyamoto Y, Ogawa H
    Current Status of Cardiovascular Medicine in the Aging Society of Japan.
    Circulation. 2018;138:965-967.
    PubMed    


    August 2018
  406. SHARKEY SW, Maron BJ, Kloner RA
    The Case for Takotsubo Cardiomyopathy (Syndrome) as a Variant of Acute Myocardial Infarction.
    Circulation. 2018;138:855-857.
    PubMed    


  407. BODEN WE, Bhatt DL
    Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease?
    Circulation. 2018;138:858-860.
    PubMed    


  408. YI-TONG W
    Letter by Wang Yi-tong Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
    Circulation. 2018;138:852.
    PubMed    


  409. ZAUNER CA, Holshouser JW, Littmann L
    Response to Letter Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
    Circulation. 2018;138:853-854.
    PubMed    


  410. TAMPAKIS A, Tampaki EC, Gurke L
    Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:848-849.
    PubMed    


  411. WANNER C, von Eynatten M, Zinman B
    Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:850-851.
    PubMed    


  412. KOH KK
    Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:846-847.
    PubMed    


  413. KYRLE PA, Eichinger S
    D-Dimer for Long-Term Risk Prediction in Patients After Acute Coronary Syndrome.
    Circulation. 2018;138:724-726.
    PubMed    


  414. HANDY CE, Quispe R, Pinto X, Blaha MJ, et al
    Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment.
    Circulation. 2018;138:727-734.
    PubMed     Abstract available


  415. MATTHEWS DR, Perkovic V, Mahaffey KW
    Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist".
    Circulation. 2018;138:660-661.
    PubMed    


  416. HNID K
    Letter by Hnid Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:653-654.
    PubMed    


  417. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:649-650.
    PubMed    


  418. KOH KK
    Letter by Koh Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:651-652.
    PubMed    


  419. DINU M, Pagliai G, Sofi F
    Response by Dinu et al to Letters Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:655.
    PubMed    


  420. LOWENSTEIN CJ, Weisfeldt ML, Mitchell JH
    Sarnoff Cardiovascular Research Foundation.
    Circulation. 2018;138:554-556.
    PubMed    


    July 2018
  421. VACCARINO V, Bremner JD, Raggi P
    Response by Vaccarino et al to Letter Regarding Article, "Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms".
    Circulation. 2018;138:548-549.
    PubMed    



  422. Correction to: European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners R
    Circulation. 2018;138:e80.
    PubMed    


  423. JIANG X, Tian H, Qiao S
    Letter by Jiang et al Regarding Article, "Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction".
    Circulation. 2018;138:543.
    PubMed    


  424. KAIER TE, Twerenbold R, Puelacher C, Marjot J, et al
    Response by Kaier et al to Letter Regarding Article, "Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction".
    Circulation. 2018;138:544-545.
    PubMed    


  425. SINGH AD, Mian A
    Letter by Singh and Mian Regarding Article, "Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms".
    Circulation. 2018;138:546-547.
    PubMed    


  426. OMLAND T
    Can Circulating B-Type Natriuretic Peptide Concentrations Guide Treatment of Obstructive Left Main Coronary Artery Disease?
    Circulation. 2018;138:479-482.
    PubMed    



  427. Correction to: ILCOR Scientific Knowledge Gaps and Clinical Research Priorities for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: A Consensus Statement.
    Circulation. 2018;138:e77.
    PubMed    



  428. Correction to: Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.
    Circulation. 2018;138:e76.
    PubMed    


  429. ANGIOLILLO DJ, Goodman SG, Bhatt DL, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.
    Circulation. 2018;138:527-536.
    PubMed     Abstract available


  430. SHEN C, Ge J
    Epidemic of Cardiovascular Disease in China.
    Circulation. 2018;138:342-344.
    PubMed    


  431. FUERNAU G, Beck J, Desch S, Eitel I, et al
    Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction - The Randomized SHOCK-COOL Trial.
    Circulation. 2018 Jul 19. pii: CIRCULATIONAHA.117.032722.
    PubMed     Abstract available


  432. MCCORD J, Newby LK, deFilippi CR
    Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction.
    Circulation. 2018;138:316-318.
    PubMed    


  433. GOLDBERG IJ, Reue K, Abumrad NA, Bickel PE, et al
    Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop.
    Circulation. 2018;138:305-315.
    PubMed     Abstract available


  434. SHEN YM, Nagalla S
    Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.
    Circulation. 2018;138:229-231.
    PubMed    


  435. BONACA MP, Sabatine MS
    Response by Bonaca and Sabatine to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Resea
    Circulation. 2018;138:222-223.
    PubMed    


  436. ALKHALIL M
    Letter by Alkhalil Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibitio
    Circulation. 2018;138:220-221.
    PubMed    


  437. CALABRO P, Gragnano F, Cesaro A
    Letter by Calabro et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhi
    Circulation. 2018;138:218-219.
    PubMed    


  438. IBRAHIM K, Shah R, McEvoy JW
    Response by Ibrahim et al to Letter Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggreg
    Circulation. 2018;138:216-217.
    PubMed    


  439. KIKKERT WJ, Delewi R, Claessen BEPM
    Letter by Kikkert et al Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With T
    Circulation. 2018;138:214-215.
    PubMed    


  440. BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
    Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2018;138:198-205.
    PubMed     Abstract available


  441. KOENIG W
    Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept?
    Circulation. 2018;138:150-153.
    PubMed    


  442. BASCOM KE, Seder DB
    Response by Bascom and Seder to Letter Regarding Article, "Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest".
    Circulation. 2018;138:120-121.
    PubMed    


  443. VOICU S, Megarbane B, Sideris G
    Letter by Voicu et al Regarding Article, "Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest".
    Circulation. 2018;138:118-119.
    PubMed    


  444. ZARZOUR A, Kim HW, Weintraub NL
    Understanding Obesity-Related Cardiovascular Disease: It's All About Balance.
    Circulation. 2018;138:64-66.
    PubMed    


  445. NASSIF ME, Kosiborod M
    Are We Ready to Bell The Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes.
    Circulation. 2018;138:4-6.
    PubMed    


  446. SHIRAKAWA K, Endo J, Kataoka M, Katsumata Y, et al
    IL-10-STAT3-Galectin-3 Axis is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
    Circulation. 2018 Jul 2. pii: CIRCULATIONAHA.118.035047.
    PubMed     Abstract available


  447. SHAH ASV, Stelzle D, Lee KK, Beck EJ, et al
    Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
    Circulation. 2018 Jul 2. pii: CIRCULATIONAHA.117.033369.
    PubMed     Abstract available


    June 2018
  448. LABARTHE DR, Lloyd-Jones DM
    50x50x50: Cardiovascular Health and the Cardiovascular Disease Endgame.
    Circulation. 2018 Jun 27. pii: CIRCULATIONAHA.118.035985.
    PubMed     Abstract available


  449. BANGALORE S, Toklu B, Patel N, Feit F, et al
    Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials.
    Circulation. 2018 Jun 26. pii: CIRCULATIONAHA.118.034456.
    PubMed     Abstract available


  450. NEUEN BL, Ohkuma T, Neal B, Matthews DR, et al
    Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data from the CANVAS Program.
    Circulation. 2018 Jun 25. pii: CIRCULATIONAHA.118.035901.
    PubMed     Abstract available


  451. RICCIOTTI E, Castro C, Tang SY, Briggs WTE, et al
    Cyclooxygenase-2, Asymmetric Dimethylarginine and the Cardiovascular Hazard from NSAIDs.
    Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.033540.
    PubMed     Abstract available


  452. ORME RC, Parker WAE, Thomas MR, Judge HM, et al
    Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI).
    Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.034790.
    PubMed     Abstract available


  453. THIENE G, Saffitz JE
    Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now.
    Circulation. 2018;137:2683-2685.
    PubMed    


  454. ZHANG M, Solomon DH, Desai RJ, Kang EH, et al
    Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study.
    Circulation. 2018 Jun 13. pii: CIRCULATIONAHA.118.033992.
    PubMed     Abstract available


  455. BOHULA EA, Wiviott SD, Giugliano RP, Park JG, et al
    Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Circulation. 2018;137:2662-2663.
    PubMed    


  456. KOH KK
    Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2660-2661.
    PubMed    


  457. CORDERO A, Bertomeu-Gonzalez V, Rodriguez-Manero M
    Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2658-2659.
    PubMed    


  458. THOMOPOULOS C, Michalopoulou H
    Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Tr
    Circulation. 2018;137:2656-2657.
    PubMed    


  459. DEL PINTO R, Ferri C, Borghi C
    Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2654-2655.
    PubMed    


  460. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Circulation. 2018;137:2635-2650.
    PubMed     Abstract available


  461. ROBERTS R
    Genetic Risk Stratification: Tipping Point for Global Primary Prevention of Coronary Artery Disease.
    Circulation. 2018;137:2554-2556.
    PubMed    


  462. UDDIN SMI, Mirbolouk M, Dardari Z, Feldman DI, et al
    Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2018 Jun 11. pii: CIRCULATIONAHA.118.033990.
    PubMed     Abstract available


  463. BADERTSCHER P, Boeddinghaus J, Twerenbold R, Nestelberger T, et al
    Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction.
    Circulation. 2018;137:2536-2538.
    PubMed    


  464. PFEFFER MA, Rutherford JD
    Therapeutic Attenuation of Cardiac Remodeling After Acute Myocardial Infarction: A Conversation With Marc A. Pfeffer, MD, PhD.
    Circulation. 2018;137:2430-2434.
    PubMed    


  465. HYMAN MC, Patel PA, Giri J
    Response by Hyman et al to Letter Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights From the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Car
    Circulation. 2018;137:2545-2546.
    PubMed    


  466. SNIECINSKI RM, Mackensen GB, Kertai MD
    Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology
    Circulation. 2018;137:2543-2544.
    PubMed    


  467. MAGNANI JW, Mujahid MS, Aronow HD, Cene CW, et al
    Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Jun 4. pii: CIR.0000000000000579.
    PubMed     Abstract available


    May 2018
  468. DEVEREAUX PJ
    Suboptimal Outcome of Myocardial Infarction After Noncardiac Surgery: Physicians Can and Should Do More.
    Circulation. 2018;137:2340-2343.
    PubMed    



  469. Correction to: Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.
    Circulation. 2018;137:e820.
    PubMed    


  470. VALLEJO-VAZ AJ, Packard CJ, Ray KK
    Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL
    Circulation. 2018;137:2419-2420.
    PubMed    


  471. KOH KK
    Letter by Koh Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From th
    Circulation. 2018;137:2417-2418.
    PubMed    


  472. LOWE AL, Collet TH, Rodondi N
    Letter by Lowe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses
    Circulation. 2018;137:2415-2416.
    PubMed    


  473. RIJNBERG FM, Hazekamp MG, Wentzel JJ, de Koning PJH, et al
    Energetics of Blood Flow in Cardiovascular Disease: Concept and Clinical Implications of Adverse Energetics in Patients With a Fontan Circulation.
    Circulation. 2018;137:2393-2407.
    PubMed     Abstract available


  474. VOLGMAN AS, Palaniappan LS, Aggarwal NT, Gupta M, et al
    Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.
    Circulation. 2018 May 24. pii: CIR.0000000000000580.
    PubMed     Abstract available


  475. KIRTANE AJ
    ORBITA2: Bringing Some Oxygen Back to PCI in Stable Ischemic Heart Disease?
    Circulation. 2018 May 22. pii: CIRCULATIONAHA.118.035331.
    PubMed     Abstract available


  476. PUYMIRAT E, Simon T, Danchin N
    Response by Puymirat et al to Letter Regarding Article, "Acute Myocardial Infarction Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST Elevation or Non-ST
    Circulation. 2018;137:2307-2308.
    PubMed    


  477. RODRIGUEZ-GRANILLO GA, Rodriguez AE, Milei J
    Letter by Rodriguez-Granillo et al Regarding Article, "Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-
    Circulation. 2018;137:2305-2306.
    PubMed    


  478. AL-LAMEE R, Howard JP, Shun-Shin MJ, Thompson D, et al
    Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease: Physiology-Stratified Analysis of ORBITA.
    Circulation. 2018 May 22. pii: CIRCULATIONAHA.118.033801.
    PubMed     Abstract available


  479. OLDGREN J, Sundstrom J
    Response by Oldgren and Sundstrom to Letter Regarding Article, "Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study".
    Circulation. 2018;137:2313.
    PubMed    


  480. YI-TONG W
    Letter by Yi-tong Regarding Article, "Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study".
    Circulation. 2018;137:2312.
    PubMed    


  481. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    PubMed    


  482. KENGNE AP, Ntsekhe M
    Challenges of Cardiovascular Disease Risk Evaluation in People Living With HIV Infection.
    Circulation. 2018;137:2215-2217.
    PubMed    


  483. LINGVAY I, Leiter LA
    Use of GLP-1 RAs in Cardiovascular Disease Prevention: A Practical Guide.
    Circulation. 2018;137:2200-2202.
    PubMed    


  484. RIMM EB, Appel LJ, Chiuve SE, Djousse L, et al
    Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2018 May 17. pii: CIR.0000000000000574.
    PubMed     Abstract available


  485. HENG EL, Diller GP, Gatzoulis MA, Babu-Narayan SV, et al
    Response by Heng et al to Letter Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2186-2187.
    PubMed    


  486. ROMEO JLR, Bogers AJJC, Mokhles MM
    Letter by Romeo et al Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2184-2185.
    PubMed    


  487. VERMA S, Bhatt DL, Bain SC, Buse JB, et al
    Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.
    Circulation. 2018;137:2179-2183.
    PubMed    


  488. SCHULTZ WM, Kelli HM, Lisko JC, Varghese T, et al
    Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions.
    Circulation. 2018;137:2166-2178.
    PubMed     Abstract available


  489. BROWN HL, Warner JJ, Gianos E, Gulati M, et al
    Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gyneco
    Circulation. 2018 May 10. pii: CIR.0000000000000582.
    PubMed    


  490. MAGNUSSEN C, Ojeda FM, Schnabel RB
    Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk
    Circulation. 2018;137:2087-2088.
    PubMed    


  491. WANG Y
    Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
    Circulation. 2018;137:2085-2086.
    PubMed    


  492. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessmen
    Circulation. 2018;137:2083-2084.
    PubMed    


  493. BARTER PJ
    High- Versus Low-Dose Statin: Effects on Cardiovascular Events and All-Cause Death.
    Circulation. 2018;137:2013-2015.
    PubMed    


  494. TAGUCHI I, Iimuro S, Iwata H, Takashima H, et al
    High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
    Circulation. 2018;137:1997-2009.
    PubMed     Abstract available


  495. MAYNE SL, Widome R, Carroll AJ, Schreiner PJ, et al
    Longitudinal Associations of Smoke-Free Policies and Incident Cardiovascular Disease: CARDIA Study.
    Circulation. 2018 May 7. pii: CIRCULATIONAHA.117.032302.
    PubMed     Abstract available


  496. KARAM N, Pechmajou L, Dumas F, Bougouin W, et al
    Comprehensive Assessment of Coronary Artery Disease in Sports-Related Sudden Cardiac Arrest.
    Circulation. 2018 May 2. pii: CIRCULATIONAHA.118.034664.
    PubMed     Abstract available


  497. GOLDWASSER D, Elizari M, Bayes de Luna A
    Response by Goldwasser et al to Letter Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"
    Circulation. 2018;137:1977-1978.
    PubMed    


  498. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"
    Circulation. 2018;137:1976.
    PubMed    


  499. BULLUCK H, Dharmakumar R, Arai AE, Berry C, et al
    Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions.
    Circulation. 2018;137:1949-1964.
    PubMed     Abstract available


  500. THOMPSON PD
    Fitness, Exercise, and Coronary Calcification.
    Circulation. 2018;137:1896-1898.
    PubMed    


    April 2018
  501. WEI WQ, Li X, Feng Q, Kubo M, et al
    LPA Variants are Associated with Residual Cardiovascular Risk in Patients Receiving Statins.
    Circulation. 2018 Apr 27. pii: CIRCULATIONAHA.117.031356.
    PubMed     Abstract available


  502. KLEINMAN ME, Perkins GD, Bhanji F, Billi JE, et al
    ILCOR Scientific Knowledge Gaps and Clinical Research Priorities for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: A Consensus Statement.
    Circulation. 2018 Apr 26. pii: CIR.0000000000000561.
    PubMed     Abstract available


  503. VAN DER LINDEN N, Wildi K, Twerenbold R, Pickering JW, et al
    Combining High Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2018 Apr 24. pii: CIRCULATIONAHA.117.032003.
    PubMed     Abstract available


  504. RUBINI GIMENEZ M, Badertscher P, Twerenbold R, Boeddinghaus J, et al
    Impact of the US Food and Drug Administration-Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial Infarction.
    Circulation. 2018;137:1867-1869.
    PubMed    


  505. HASEEB S, Alexander B, Baranchuk A
    Response by Haseeb et al to Letter Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review".
    Circulation. 2018;137:1880-1881.
    PubMed    


  506. THORNTON SN
    Letter by Thornton Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review".
    Circulation. 2018;137:1879.
    PubMed    


  507. HUANG ZP, Wang DZ
    miR-22 in Smooth Muscle Cells: A Potential Therapy for Cardiovascular Disease.
    Circulation. 2018;137:1842-1845.
    PubMed    


  508. FERNANDEZ-JIMENEZ R, Martin-Garcia A, Barreiro-Perez M, Sanchez-Gonzalez J, et al
    Response by Fernandez-Jimenez et al to Letters Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1754-1755.
    PubMed    


  509. STIERMAIER T, Bogaert J, Eitel I
    Letter by Stiermaier et al Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1752-1753.
    PubMed    


  510. SACHA J, Feusette P
    Letter by Sacha and Feusette Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1750-1751.
    PubMed    


  511. BULLUCK H, Hausenloy DJ
    Letter by Bulluck and Hausenloy Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1748-1749.
    PubMed    


  512. VERHEUGT FWA
    Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
    Circulation. 2018;137:1655-1657.
    PubMed    


  513. REDFORS B, Chen S, Crowley A, Ben-Yehuda O, et al
    B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial.
    Circulation. 2018 Apr 17. pii: CIRCULATIONAHA.118.033631.
    PubMed     Abstract available


  514. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Response by Ahmad et al to Letter Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK".
    Circulation. 2018;137:1761-1762.
    PubMed    


  515. MEWTON N, Bergerot C, Cornu C
    Letter by Mewton et al Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK".
    Circulation. 2018;137:1759-1760.
    PubMed    


  516. PACK QR, Priya A, Lagu TC, Pekow PS, et al
    Inpatient Echocardiography Use for Common Cardiovascular Conditions.
    Circulation. 2018;137:1745-1747.
    PubMed    


  517. BAIBHAV B, Gedela M, Moulton M, Pavlides G, et al
    Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease.
    Circulation. 2018;137:1731-1739.
    PubMed     Abstract available


  518. BAKAEEN FG, Svensson LG
    Why Don't We Kill 2 Birds with 1 Stone? Less Adverse Cardiac Events and Improved Survival With Multiarterial Coronary Artery Bypass Grafting.
    Circulation. 2018;137:1708-1711.
    PubMed    


  519. GAUDINO M, Fremes SE, Taggart DP
    Continuing Conundrum of Multiple Arterial Conduits for Coronary Artery Bypass Grafting.
    Circulation. 2018;137:1658-1660.
    PubMed    


  520. PATEL KV, Pandey A, de Lemos JA
    A Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine.
    Circulation. 2018 Apr 11. pii: CIRCULATIONAHA.118.035289.
    PubMed     Abstract available


  521. FIOL-SALA M, Bayes de Luna A
    Response by Fiol-Sala and Bayes de Luna to Letter Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"
    Circulation. 2018;137:1653.
    PubMed    


  522. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"
    Circulation. 2018;137:1652.
    PubMed    


  523. NALLAMOTHU BK, Hill JA
    Response by Nallamothu and Hill to Letter Regarding Article, "Preprints and Cardiovascular Science: Prescient or Premature?"
    Circulation. 2018;137:1643-1644.
    PubMed    


  524. KATRITSIS DG
    Letter by Katritsis Regarding Article, "Preprints and Cardiovascular Science: Prescient or Premature?"
    Circulation. 2018;137:1641-1642.
    PubMed    


  525. SHARIFZADEHGAN A, Marijon E, Bougouin W, Karam N, et al
    Sudden Cardiovascular Arrest During Sexual Intercourse.
    Circulation. 2018;137:1638-1640.
    PubMed    


  526. DUNBAR SB, Khavjou OA, Bakas T, Hunt G, et al
    Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Circulation. 2018 Apr 9. pii: CIR.0000000000000570.
    PubMed     Abstract available


  527. TIKKANEN E, Gustafsson S, Ingelsson E
    Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study.
    Circulation. 2018 Apr 9. pii: CIRCULATIONAHA.117.032432.
    PubMed     Abstract available


  528. SABATINE MS, De Ferrari GM, Giugliano RP, Huber K, et al
    Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER.
    Circulation. 2018 Apr 6. pii: CIRCULATIONAHA.118.034309.
    PubMed     Abstract available


  529. VALLEJO-VAZ AJ, Fayyad R, Boekholdt SM, Hovingh GK, et al
    Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial.
    Circulation. 2018 Apr 4. pii: CIRCULATIONAHA.117.032318.
    PubMed     Abstract available


  530. OLDE ENGBERINK RHG, van den Born BH, Peters-Sengers H, Vogt L, et al
    Response by Olde Engberink et al to Letter Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk".
    Circulation. 2018;137:1538-1539.
    PubMed    


  531. GRAUDAL N, Mente A
    Letter by Graudal and Mente Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk".
    Circulation. 2018;137:1536-1537.
    PubMed    


  532. AUGER N, Potter BJ, Bilodeau-Bertrand M, Paradis G, et al
    Long-Term Risk of Cardiovascular Disease in Women Who Have Had Infants With Heart Defects.
    Circulation. 2018 Apr 2. pii: CIRCULATIONAHA.117.030277.
    PubMed     Abstract available


    March 2018
  533. PASUPATHY S, Tavella R, Beltrame JF
    Response by Pasupathy et al to Letters Regarding Article, "Early Use of N-acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Inf
    Circulation. 2018;137:1424-1425.
    PubMed    


  534. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Tria
    Circulation. 2018;137:1422-1423.
    PubMed    


  535. MANSOUR A, Le Breton H, Auffret V
    Letter by Mansour et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM
    Circulation. 2018;137:1420-1421.
    PubMed    


  536. KHAN AA, Boyle AJ
    Letter by Khan and Boyle Regarding Article, "Early Use of N-Acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The
    Circulation. 2018;137:1418-1419.
    PubMed    


  537. NEELAND IJ, Poirier P, Despres JP
    Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.
    Circulation. 2018;137:1391-1406.
    PubMed     Abstract available


  538. DELGADO V, Hundley WG
    Added Value of Cardiovascular Magnetic Resonance in Primary Mitral Regurgitation.
    Circulation. 2018;137:1361-1363.
    PubMed    


  539. BRILAKIS ES
    Innovations in Radiation Safety During Cardiovascular Catheterization.
    Circulation. 2018;137:1317-1319.
    PubMed    


  540. THIELE H, Desch S
    CULPRIT-SHOCK (Culprit Lesion Only PCI Versus Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock): Implications on Guideline Recommendations.
    Circulation. 2018;137:1314-1316.
    PubMed    


  541. ZAUNER CA, Holshouser JW, Littmann L
    Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease.
    Circulation. 2018;137:1287-1289.
    PubMed    


  542. ANDERSSON C, Lyass A, Lin H, Kober L, et al
    Association of Genetic Variation in Coronary Artery Disease-Related Loci With the Risk of Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Circulation. 2018;137:1290-1292.
    PubMed    


  543. TURER CB, Brady TM, de Ferranti SD
    Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.
    Circulation. 2018;137:1256-1259.
    PubMed    


  544. BETHEL MA, McMurray JJV
    Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist.
    Circulation. 2018;137:1218-1220.
    PubMed    


  545. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Widening Racial Differences in Risks for Coronary Heart Disease.
    Circulation. 2018;137:1195-1197.
    PubMed    


  546. SCOTT JM, Nilsen TS, Gupta D, Jones LW, et al
    Exercise Therapy and Cardiovascular Toxicity in Cancer.
    Circulation. 2018;137:1176-1191.
    PubMed     Abstract available


  547. CREA F, Liuzzo G
    Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study).
    Circulation. 2018;137:1100-1102.
    PubMed    


  548. BOHULA EA, Giugliano RP, Leiter LA, Verma S, et al
    Inflammatory and Cholesterol Risk in the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk).
    Circulation. 2018 Mar 12. pii: CIRCULATIONAHA.118.034032.
    PubMed     Abstract available


  549. FRANCHI F, Rollini F, Rivas Rios J, Rivas A, et al
    Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP (Switching Antiplatelet Therapy)-4 Study.
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.033983.
    PubMed     Abstract available


  550. RADHOLM K, Figtree G, Perkovic V, Solomon SD, et al
    Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.034222.
    PubMed     Abstract available


  551. SMILOWITZ NR, Beckman JA, Sherman SE, Berger JS, et al
    Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery.
    Circulation. 2018 Mar 10. pii: CIRCULATIONAHA.117.032086.
    PubMed     Abstract available


  552. BLEWER AL, Abella BS
    Unmeasured Interface in Emergency Cardiovascular Care: How Do Dispatch-Assisted Telephone Cardiopulmonary Resuscitation and Bystander Training Interact?
    Circulation. 2018;137:996-998.
    PubMed    


    February 2018
  553. KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
    Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of C
    Circulation. 2018;137:989-991.
    PubMed    


  554. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovas
    Circulation. 2018;137:988.
    PubMed    


  555. TAEGTMEYER H, Karlstaedt A
    Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Card
    Circulation. 2018;137:986-987.
    PubMed    


  556. KOH KK
    Letter by Koh Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in
    Circulation. 2018;137:984-985.
    PubMed    


  557. TAMPAKI EC, Tampakis A, Pantos C
    Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular O
    Circulation. 2018;137:982-983.
    PubMed    


  558. KUEHN BM
    Gene-Editing Technology Accelerates Cardiovascular Research: Clinical Applications Being Explored.
    Circulation. 2018;137:973-974.
    PubMed    


  559. HICKS KA, Mahaffey KW, Mehran R, Nissen SE, et al
    2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
    Circulation. 2018;137:961-972.
    PubMed     Abstract available


  560. ANDERSON CAM
    Dietary Patterns to Reduce Weight and Optimize Cardiovascular Health: Persuasive Evidence for Promoting Multiple, Healthful Approaches.
    Circulation. 2018 Feb 26. pii: CIRCULATIONAHA.117.031429.
    PubMed     Abstract available


  561. SOFI F, Dinu M, Pagliai G, Cesari F, et al
    Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet).
    Circulation. 2018 Feb 26. pii: CIRCULATIONAHA.117.030088.
    PubMed     Abstract available


  562. HAYES SN, Kim ESH, Saw J, Adlam D, et al
    Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Feb 22. pii: CIR.0000000000000564.
    PubMed     Abstract available


  563. PAYNTER NP, Balasubramanian R, Giulianini F, Wang DD, et al
    Metabolic Predictors of Incident Coronary Heart Disease in Women.
    Circulation. 2018;137:841-853.
    PubMed     Abstract available


  564. VACCARINO V, Sullivan S, Hammadah M, Wilmot K, et al
    Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms.
    Circulation. 2018;137:794-805.
    PubMed     Abstract available


  565. LICHTMAN JH, Leifheit EC, Safdar B, Bao H, et al
    Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction: Evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients).
    Circulation. 2018;137:781-790.
    PubMed     Abstract available


  566. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
    Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
    Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
    PubMed     Abstract available


  567. LERCHENMULLER C, Lerchenmueller MJ, Sorenson O
    Long-Term Analysis of Sex Differences in Prestigious Authorships in Cardiovascular Research Supported by the National Institutes of Health.
    Circulation. 2018;137:880-882.
    PubMed    


  568. ZOET GA, Benschop L, Boersma E, Budde RPJ, et al
    Prevalence of Subclinical Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography in 45- to 55-Year-Old Women With a History of Preeclampsia.
    Circulation. 2018;137:877-879.
    PubMed    


  569. WEI J, Bakir M, Darounian N, Li Q, et al
    Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
    Circulation. 2018;137:874-876.
    PubMed    


  570. MINISSIAN MB, Kilpatrick S, Eastwood JA, Robbins WA, et al
    Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease.
    Circulation. 2018;137:865-871.
    PubMed     Abstract available


  571. O'NEIL A, Scovelle AJ, Milner AJ, Kavanagh A, et al
    Gender/Sex as a Social Determinant of Cardiovascular Risk.
    Circulation. 2018;137:854-864.
    PubMed     Abstract available


  572. PINA IL, Zheng Q, She L, Szwed H, et al
    Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
    Circulation. 2018;137:771-780.
    PubMed     Abstract available


  573. GRAVES CR, Davis SF
    Cardiovascular Complications in Pregnancy: It Is Time for Action.
    Circulation. 2018 Feb 19. pii: CIRCULATIONAHA.117.031592.
    PubMed     Abstract available


  574. SAVONITTO S, Ferri LA, Piatti L, Grosseto D, et al
    A Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization.
    Circulation. 2018 Feb 19. pii: CIRCULATIONAHA.117.032180.
    PubMed     Abstract available


  575. TRIANT VA, Perez J, Regan S, Massaro JM, et al
    Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Circulation. 2018 Feb 14. pii: CIRCULATIONAHA.117.028975.
    PubMed     Abstract available



  576. Correction to: Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Pr
    Circulation. 2018;137:e29.
    PubMed    


  577. HADLEY MB, Baumgartner J, Vedanthan R
    Developing a Clinical Approach to Air Pollution and Cardiovascular Health.
    Circulation. 2018;137:725-742.
    PubMed     Abstract available


  578. KHERA A, Greenland P
    Coronary Artery Calcium: If Measuring Once Is Good, Is Twice Better?
    Circulation. 2018;137:680-683.
    PubMed    


  579. ASRRESS KN, Williams R, Lockie T, Khawaja MZ, et al
    Response by Asrress et al to Letter Regarding Article, "Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise".
    Circulation. 2018;137:755-756.
    PubMed    


  580. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise".
    Circulation. 2018;137:754.
    PubMed    


  581. COLLET C, Katagiri Y, Miyazaki Y, Asano T, et al
    Impact of Coronary Remodeling on Fractional Flow Reserve.
    Circulation. 2018;137:747-749.
    PubMed    


  582. KONG P, Shinde AV, Su Y, Russo I, et al
    Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium.
    Circulation. 2018;137:707-724.
    PubMed     Abstract available


  583. GOTTESMAN RF
    Survivor's Remorse: Is There an Increased Risk of Dementia After Surviving a Myocardial Infarction?
    Circulation. 2018;137:578-580.
    PubMed    


  584. CAO D, Schiattarella GG, Villalobos E, Jiang N, et al
    Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury.
    Circulation. 2018 Feb 1. pii: CIRCULATIONAHA.117.031046.
    PubMed     Abstract available


  585. MEHTA LS, Watson KE, Barac A, Beckie TM, et al
    Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Feb 1. pii: CIR.0000000000000556.
    PubMed     Abstract available


    January 2018
  586. MERGHANI A, Maestrini V, Rosmini S, Cox AT, et al
    Response by Merghani et al to Letters Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Circulation. 2018;137:541-542.
    PubMed    


  587. SCHMERMUND A
    Letter by Schmermund Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Circulation. 2018;137:539-540.
    PubMed    


  588. HARRELL TE, Stoebner RA, Boswell GE
    Letter by Harrell et al Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Circulation. 2018;137:537-538.
    PubMed    


  589. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Circulation. 2018;137:536.
    PubMed    


  590. RENA G, Lang CC
    Repurposing Metformin for Cardiovascular Disease.
    Circulation. 2018;137:422-424.
    PubMed    


  591. DEFILIPPI C, Seliger S
    The Cardiac Troponin Renal Disease Diagnostic Conundrum: Past, Present, and Future.
    Circulation. 2018;137:452-454.
    PubMed    


  592. FARRE J, Wellens HJ
    Unique ECG During Sinus Rhythm in a Patient With a Postmyocardial Infarction-Sustained Ventricular Tachycardia.
    Circulation. 2018;137:527-530.
    PubMed    


  593. KUEHN BM
    Sham-Controlled Trial Questions Benefit of Stents for Stable Angina.
    Circulation. 2018;137:519-520.
    PubMed    


  594. ALI ZA, Gao R, Kimura T, Onuma Y, et al
    Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
    Circulation. 2018;137:464-479.
    PubMed     Abstract available


  595. SIMES J, Robledo KP, White HD, Espinoza D, et al
    D-dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events and Cancer in Stable Coronary Heart Disease Patients: The LIPID Study.
    Circulation. 2018 Jan 24. pii: CIRCULATIONAHA.117.029901.
    PubMed     Abstract available


  596. HOFMANN R, James SK
    Routine Oxygen Supplementation in Acute Cardiovascular Disease: The End of a Paradigm?
    Circulation. 2018;137:320-322.
    PubMed    


  597. SOTANANUSAK T, Meemook K
    Asymptomatic ST-Segment-Elevation ECG in Patient With Kidney Failure.
    Circulation. 2018;137:402-404.
    PubMed    


  598. PANDEY A, Omar W, Ayers C, LaMonte M, et al
    Sex and Race Differences in Lifetime Risk of Heart Failure with Preserved Ejection Fraction and Heart Failure with Reduced Ejection Fraction.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.031622.
    PubMed     Abstract available


  599. RADFORD NB, DeFina LF, Leonard D, Barlow CE, et al
    Cardiorespiratory Fitness, Coronary Artery Calcium and Cardiovascular Disease Events in a Cohort of Generally Healthy, Middle Aged Men: Results from the Cooper Center Longitudinal Study.
    Circulation. 2018 Jan 17. pii: CIRCULATIONAHA.117.032708.
    PubMed     Abstract available


  600. BARTOS JA, Doonan AL, Yannopoulos D
    Identifying Candidates for Advanced Hemodynamic Support After Cardiac Arrest.
    Circulation. 2018;137:283-285.
    PubMed    


  601. WANG Y, Tan X, Gao H, Yuan H, et al
    Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection.
    Circulation. 2018;137:259-269.
    PubMed     Abstract available


  602. BASCOM KE, Dziodzio J, Vasaiwala S, Mooney M, et al
    Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest.
    Circulation. 2018;137:273-282.
    PubMed     Abstract available


  603. EMDIN CA, Khera AV, Klarin D, Natarajan P, et al
    Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling.
    Circulation. 2018;137:222-232.
    PubMed     Abstract available


  604. IANIRO G, Cammarota G, Gasbarrini A
    Letter by Ianiro et al Regarding Article, "Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium".
    Circulation. 2018;137:213-214.
    PubMed    


  605. JOLLY SS, Gao P, Cairns JA, Yusuf S, et al
    Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI).
    Circulation. 2018;137:206-209.
    PubMed    


  606. BEDDHU S, Chertow GM, Cheung AK, Cushman WC, et al
    Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Circulation. 2018;137:134-143.
    PubMed     Abstract available



  607. Correction to: 2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular
    Circulation. 2018;137:e14.
    PubMed    


    December 2017
  608. GIUGLIANO RP, Cannon CP, Blazing MA, Nicolau JC, et al
    Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT.
    Circulation. 2017 Dec 20. pii: CIRCULATIONAHA.117.030950.
    PubMed     Abstract available



  609. Correction to: Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2017;136:e469.
    PubMed    


  610. BENSON MD, Yang Q, Ngo D, Zhu Y, et al
    The Genetic Architecture of the Cardiovascular Risk Proteome.
    Circulation. 2017 Dec 19. pii: CIRCULATIONAHA.117.029536.
    PubMed     Abstract available



  611. Correction to: 2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2017;136:e468.
    PubMed    


  612. PAZOKI R, Dehghan A, Evangelou E, Warren H, et al
    Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations with Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2017 Dec 18. pii: CIRCULATIONAHA.117.030898.
    PubMed     Abstract available


  613. GOLDSTONE AB, Chiu P, Baiocchi M, Wang H, et al
    Second Arterial versus Venous Conduits for Multi-Vessel Coronary Artery Bypass Surgery in California.
    Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.030959.
    PubMed     Abstract available


  614. GAO L, Gregorich ZR, Zhu W, Mattapally S, et al
    Large Cardiac-Muscle Patches Engineered from Human Induced-Pluripotent Stem-Cell-Derived Cardiac Cells Improve Recovery from Myocardial Infarction in Swine.
    Circulation. 2017 Dec 12. pii: CIRCULATIONAHA.117.030785.
    PubMed     Abstract available


  615. AHN JM, Park SJ
    Response by Ahn and Park to Letter Regarding Article, "Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)"
    Circulation. 2017;136:2393-2394.
    PubMed    


  616. JIN-SHAN H, Xue-Bin L
    Letter by Jin-Shan and Xue-Bin Regarding Article, "Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)".
    Circulation. 2017;136:2392.
    PubMed    


  617. HAN YL, Rutherford JD
    Recent Evolution of the Treatment of Coronary Artery Disease in China: A Conversation With Ya-Ling Han, MD, PhD.
    Circulation. 2017;136:2298-2302.
    PubMed    


  618. FRANKENREITER S, Bednarczyk P, Kniess A, Bork NI, et al
    cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Circulation. 2017;136:2337-2355.
    PubMed     Abstract available


  619. ZHANG L, Wei TT, Li Y, Li J, et al
    Functional Metabolomics Characterizes a Key Role for N-Acetyl-Neuraminic Acid in Coronary Artery Diseases.
    Circulation. 2017 Dec 6. pii: CIRCULATIONAHA.117.031139.
    PubMed     Abstract available


    November 2017
  620. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)".
    Circulation. 2017;136:2202-2203.
    PubMed    


  621. YAN W, Guo Y, Tao L, Lau WB, et al
    C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.
    Circulation. 2017;136:2162-2177.
    PubMed     Abstract available


  622. CHANG AM, Litt HI, Snyder BS, Gatsonis C, et al
    Impact of Coronary Computed Tomography Angiography Findings on Initiation of Cardioprotective Medications.
    Circulation. 2017;136:2195-2197.
    PubMed    


  623. KOSKINEN J, Juonala M, Dwyer T, Venn A, et al
    Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: The International Childhood Cardiovascular Cohort (i3C) Consortium.
    Circulation. 2017 Nov 23. pii: CIRCULATIONAHA.117.029726.
    PubMed     Abstract available


  624. HORCKMANS M, Bianchini M, Santovito D, Megens RTA, et al
    Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function After Myocardial Infarction.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.028833.
    PubMed     Abstract available


  625. JENSEN MK, Aroner SA, Mukamal KJ, Furtado JD, et al
    HDL Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
    Circulation. 2017 Nov 21. pii: CIRCULATIONAHA.117.031276.
    PubMed     Abstract available


  626. CICCARELLI G, Barbato E, Toth GG, Gahl B, et al
    Angiography versus Hemodynamics to Predict the Natural History of Coronary Stenoses: A FAME 2-Substudy.
    Circulation. 2017 Nov 21. pii: CIRCULATIONAHA.117.028782.
    PubMed     Abstract available


  627. CHAPMAN AR, Shah ASV, Lee KK, Anand A, et al
    Long Term Outcomes in Patients with Type 2 Myocardial Infarction and Myocardial Injury.
    Circulation. 2017 Nov 17. pii: CIRCULATIONAHA.117.031806.
    PubMed     Abstract available


  628. LEHMANN N, Erbel RA, Mahabadi AA, Rauwolf M, et al
    Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the Heinz Nixdorf Recall (HNR) Study.
    Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.116.027034.
    PubMed     Abstract available


  629. JOLLIS JG, Al-Khalidi HR, Roettig ML, Berger PB, et al
    Impact of Regionalization of ST Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services Transported Patients Presenting to Hospitals with Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.
    Circulation. 2017 Nov 14. pii: CIRCULATIONAHA.117.032446.
    PubMed     Abstract available


  630. THAN MP, Pickering JW, Dryden JM, Lord SJ, et al
    ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway.
    Circulation. 2017 Nov 14. pii: CIRCULATIONAHA.117.031984.
    PubMed     Abstract available


  631. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Response by Perez de Isla et al to Letter Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1984.
    PubMed    


  632. NATALE F, Di Maio M, Calabro P
    Letter by Natale et al Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1982-1983.
    PubMed    


  633. KHERA R, Hong JC, Saxena A, Arrieta A, et al
    Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.030128.
    PubMed     Abstract available


  634. UDELL JA, Yuan Z, Rush T, Sicignano NM, et al
    Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Co-Transporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.031227.
    PubMed     Abstract available


  635. BONACA MP, Nault P, Giugliano RP, Keech AC, et al
    Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032235.
    PubMed     Abstract available


  636. MAHAFFEY KW, Neal B, Perkovic V, de Zeeuw D, et al
    Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032038.
    PubMed     Abstract available


  637. VERMA S, Mazer CD, Al-Omran M, Inzucchi SE, et al
    Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032031.
    PubMed     Abstract available


  638. WENG LC, Preis SR, Hulme OL, Larson MG, et al
    Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Circulation. 2017 Nov 12. pii: CIRCULATIONAHA.117.031431.
    PubMed     Abstract available


  639. BURSTEIN B, Altobelli KK, Williams K, Cannon CP, et al
    Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Circulation. 2017;136:1860-1862.
    PubMed    


  640. DRAGER LF, McEvoy RD, Barbe F, Lorenzi-Filho G, et al
    Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science.
    Circulation. 2017;136:1840-1850.
    PubMed     Abstract available


  641. LEE JM, Hwang D, Park J, Zhang J, et al
    Exploring Coronary Circulatory Response to Stenosis and Its Association With Invasive Physiologic Indexes Using Absolute Myocardial Blood Flow and Coronary Pressure.
    Circulation. 2017;136:1798-1808.
    PubMed     Abstract available


  642. OLASVEENGEN TM, de Caen AR, Mancini ME, Maconochie IK, et al
    2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000541.
    PubMed     Abstract available


  643. ATKINS DL, de Caen AR, Berger S, Samson RA, et al
    2017 American Heart Association Focused Update on Pediatric Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardio pulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000540.
    PubMed     Abstract available


  644. KLEINMAN ME, Goldberger ZD, Rea T, Swor RA, et al
    2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardio pulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000539.
    PubMed     Abstract available


  645. TWERENBOLD R, Badertscher P, Boeddinghaus J, Nestelberger T, et al
    0/1-Hour Triage Algorithm for Myocardial Infarction in Patients with Renal Dysfunction.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028901.
    PubMed     Abstract available


  646. BENNAGHMOUCH N, de Veer AJWM, Bode K, Mahmoodi BK, et al
    The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028513.
    PubMed     Abstract available


  647. FEARON WF, Nishi T, De Bruyne B, Boothroyd DB, et al
    Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Mul
    Circulation. 2017 Nov 2. pii: CIRCULATIONAHA.117.031907.
    PubMed     Abstract available


    October 2017
  648. GAUDINO M, Antoniades C, Benedetto U, Deb S, et al
    Mechanisms, Consequences, and Prevention of Coronary Graft Failure.
    Circulation. 2017;136:1749-1764.
    PubMed     Abstract available


  649. HENG EL, Gatzoulis MA, Uebing A, Sethia B, et al
    Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study.
    Circulation. 2017;136:1703-1713.
    PubMed     Abstract available


  650. IRIBARNE A, Schmoker JD, Malenka DJ, Leavitt BJ, et al
    Does Use of Bilateral Internal Mammary Artery Grafting Reduce Long-Term Risk of Repeat Coronary Revascularization? A Multicenter Analysis.
    Circulation. 2017;136:1676-1685.
    PubMed     Abstract available


  651. RUEL M, Gardner TJ
    Introduction to the 2017 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2017;136:1675.
    PubMed    


  652. CAVALLARI I, Morrow DA, Creager MA, Olin J, et al
    Frequency, Predictors and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients with Symptomatic Atherosclerosis.
    Circulation. 2017 Oct 30. pii: CIRCULATIONAHA.117.031062.
    PubMed     Abstract available


  653. KRITTANAWONG C
    Future Physicians in the Era of Precision Cardiovascular Medicine.
    Circulation. 2017;136:1572-1574.
    PubMed    


  654. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    PubMed     Abstract available


  655. CARNETHON MR, Pu J, Howard G, Albert MA, et al
    Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Oct 23. pii: CIR.0000000000000534.
    PubMed     Abstract available


  656. MCEVOY JW, Ibrahim K, Kickler TS, Clarke WA, et al
    Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial.
    Circulation. 2017 Oct 18. pii: CIRCULATIONAHA.117.031678.
    PubMed     Abstract available


  657. VAN DIEPEN S, Katz JN, Albert NM, Henry TD, et al
    Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.
    Circulation. 2017;136:e232-e268.
    PubMed     Abstract available


  658. BORTOLOTTI F, Ruozi G, Falcione A, Doimo S, et al
    In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells.
    Circulation. 2017;136:1509-1524.
    PubMed     Abstract available


  659. WOLSK E, Claggett B, Diaz R, Dickstein K, et al
    Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Circulation. 2017;136:1560-1562.
    PubMed    


  660. MAGNUSSEN C, Niiranen TJ, Ojeda F, Gianfagna F, et al
    Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
    Circulation. 2017 Oct 16. pii: CIRCULATIONAHA.117.028981.
    PubMed     Abstract available


  661. MCCARROLL CS, He W, Foote K, Bradley A, et al
    Runx1 Deficiency Protects Against Adverse Cardiac Remodeling Following Myocardial Infarction.
    Circulation. 2017 Oct 13. pii: CIRCULATIONAHA.117.028911.
    PubMed     Abstract available


  662. SUNA G, Wojakowski W, Lynch M, Barallobre-Barreiro J, et al
    Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.
    Circulation. 2017 Oct 13. pii: CIRCULATIONAHA.116.023381.
    PubMed     Abstract available


  663. SUNDBOLL J, Hovath-Puho E, Adelborg K, Schmidt M, et al
    Higher Risk of Vascular Dementia in Myocardial Infarction Survivors.
    Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.029127.
    PubMed     Abstract available


  664. HASEEB S, Alexander B, Baranchuk A
    Wine and Cardiovascular Health: A Comprehensive Review.
    Circulation. 2017;136:1434-1448.
    PubMed     Abstract available


  665. LACRAZ GPA, Junker JP, Gladka MM, Molenaar B, et al
    Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury.
    Circulation. 2017;136:1396-1409.
    PubMed     Abstract available


  666. MILLER-HODGES EV, Anand A, Shah ASV, Chapman AR, et al
    High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients with Renal Impairment Presenting with Suspected Acute Coronary Syndrome.
    Circulation. 2017 Oct 4. pii: CIRCULATIONAHA.117.030320.
    PubMed     Abstract available


  667. SMOLDEREN KGE, Gosch KG, Buchanan DM, Spertus JA, et al
    Response by Smolderen et al to Letter Regarding Article, "Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial
    Circulation. 2017;136:1355-1356.
    PubMed    


  668. MA LL, Kong FJ, Ge JB
    Letter by Ma et al Regarding Article, "Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients
    Circulation. 2017;136:1353-1354.
    PubMed    


  669. HEAD SJ, Milojevic M, Taggart DP, Puskas JD, et al
    Current Practice of State-of-the-Art Surgical Coronary Revascularization.
    Circulation. 2017;136:1331-1345.
    PubMed     Abstract available


  670. ARAI AE
    Time-Varying Edema Requires Cautious Interpretation of Myocardium at Risk and Infarct Size by All Imaging Methods.
    Circulation. 2017;136:1301-1303.
    PubMed    


  671. WONG KL, Taner T, Smith BH, Kushwaha SS, et al
    Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation.
    Circulation. 2017;136:1350-1352.
    PubMed    


    September 2017
  672. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    PubMed     Abstract available


  673. BERRY C, McClure JD, Oldroyd KG
    Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.030430.
    PubMed     Abstract available


  674. GOYAL A, Gluckman TJ, Tcheng JE
    What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) Codes and Type 2 Myocardial Infarction.
    Circulation. 2017;136:1180-1182.
    PubMed    


  675. WILSON PWF, Gagnon D
    Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors: A Challenge to Improve Usual Care.
    Circulation. 2017;136:1204-1206.
    PubMed    


  676. SUNDSTROM J, Hedberg J, Thuresson M, Aarskog P, et al
    Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study.
    Circulation. 2017;136:1183-1192.
    PubMed     Abstract available


  677. KAIER TE, Twerenbold R, Puelacher C, Marjot J, et al
    Direct Comparison of Cardiac Myosin-Binding Protein C with Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028084.
    PubMed     Abstract available


  678. REBOLL MR, Korf-Klingebiel M, Klede S, Polten F, et al
    Endoplasmic Reticulum Membrane Protein Complex Subunit 10 (EMC10) is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
    Circulation. 2017 Sep 20. pii: CIRCULATIONAHA.117.029980.
    PubMed     Abstract available


  679. CREA F, Libby P
    Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment.
    Circulation. 2017;136:1155-1166.
    PubMed     Abstract available


  680. QUAIFE-RYAN GA, Sim CB, Ziemann M, Kaspi A, et al
    Multicellular Transcriptional Analysis of Mammalian Heart Regeneration.
    Circulation. 2017;136:1123-1139.
    PubMed     Abstract available


  681. NALLAMOTHU BK, Hill JA
    Preprints and Cardiovascular Science: Prescient or Premature?
    Circulation. 2017 Sep 14. pii: CIRCULATIONAHA.117.031238.
    PubMed     Abstract available


  682. WANNER C, Lachin JM, Inzucchi SE, Fitchett D, et al
    Empagliflozin and Clinical Outcomes in Patients with Type 2 Diabetes, Established Cardiovascular Disease and Chronic Kidney Disease.
    Circulation. 2017 Sep 13. pii: CIRCULATIONAHA.117.028268.
    PubMed     Abstract available


  683. LINDAHL B, Baron T, Erlinge D, Hadziosmanovic N, et al
    Response by Lindahl et al to Letter Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease".
    Circulation. 2017;136:1082-1083.
    PubMed    


  684. CILIBERTI G, Capucci A
    Letter by Ciliberti and Capucci Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease".
    Circulation. 2017;136:1080-1081.
    PubMed    


  685. DEHARO P, Ducrocq G, Bode C, Cohen M, et al
    Timing of Angiography and Outcomes in High-Risk Patients with Non-ST Segment Elevation Myocardial Infarction Managed Invasively: Insights from the TAO Trial.
    Circulation. 2017 Sep 11. pii: CIRCULATIONAHA.117.029779.
    PubMed     Abstract available


    August 2017
  686. WANG WE, Li L, Xia X, Fu W, et al
    Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury.
    Circulation. 2017;136:834-848.
    PubMed     Abstract available


  687. ARMSTRONG PW, Welsh RC
    Recalibrating Reperfusion Waypoints.
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030869.
    PubMed     Abstract available


    May 2017
  688. JOLLY SS, James S, Dzavik V, Cairns JA, et al
    Response by Jolly et al to Letters Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1103-e1104.
    PubMed    


  689. SHAH R
    Letter by Shah Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1101-e1102.
    PubMed    


  690. JURADO-ROMAN A, Sanchez-Perez I, Lozano-Ruiz-Poveda F
    Letter by Jurado-Roman et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1099-e1100.
    PubMed    


  691. KARAMASIS GV, Davies JR, Clesham GJ
    Letter by Karamasis et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1097-e1098.
    PubMed    


  692. DAVIDSON KW
    Waiting for Godot: Engaging in Discussions About Depression Care in Patients With Acute Myocardial Infarction While Waiting for a Definitive Trial That Never Appears.
    Circulation. 2017;135:1690-1692.
    PubMed    


  693. SMOLDEREN KG, Spertus JA, Gosch K, Dreyer RP, et al
    Depression Treatment and Health Status Outcomes in Young Patients With Acute Myocardial Infarction: Insights From the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients).
    Circulation. 2017;135:1762-1764.
    PubMed    


    March 2017
  694. CAPOULADE R, Bowdish M, Kron IL, Smith P, et al
    Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
    Circulation. 2017;135:e785-e786.
    PubMed    


  695. POCAR M
    Letter by Pocar Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
    Circulation. 2017;135:e783-e784.
    PubMed    


    January 2017
  696. ATZLER D, McAndrew DJ, Cordts K, Schneider JE, et al
    Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure.
    Circulation. 2017;135:400-402.
    PubMed    


  697. OVBIAGELE B, Wang J, Johnston SC, Wang A, et al
    Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention.
    Circulation. 2017;135:315-316.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: